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ABSTRACT 
 
Fish kills are a common phenomenon in Prince Edward Island (Canada) and their 
cause often remains unexplained. I hypothesized that fish exposure to selected 
environmental toxicants leads to increased mortality and morbidity by depressing cardiac 
function, precipitated by suppression of cardiac electrical activity and rhythm 
disturbances. These rhythm disturbances could result from toxicant-induced changes in 
the function of specific cardiac ion channels.  
Recently, the zebrafish heart has been shown to hold promise as a suitable model 
to study cardiac cellular electrophysiology. The purpose of the present study was to 
evaluate the effects of selected environmental toxicants on cardiac action potential 
morphology. More specifically, the present work focused on evaluating the effects on 
atrial action potential in adult zebrafish of: 1) acetylcholine (1-10 µM); 2) a documented 
acetylcholinesterase inhibitor, physostigmine (50 µM); 3) pesticides with 
acetylcholinesterase inhibition properties that are commonly used in Prince Edward 
Island (mancozeb and phorate). Zebrafish hearts were isolated under anesthesia and 
action potentials were recorded in vitro using a standard single microelectrode technique. 
Action potential morphology was then assessed by measuring parameters including action 
potential duration (APD) and action potential amplitude (APA).  
Results revealed that in vitro exposures to high concentrations of acetylcholine 
and physostigmine led to suppression of cardiac electrical activity by significantly 
reducing APD and APA, a phenomenon known as cholinergic non-excitability. 
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Experiments evaluating the effects of commercial pesticides (mancozeb and phorate) did 
not reveal similar effects. 
This study supports the possibility that environmental toxicants containing 
acetylcholinesterase inhibitors may participate in fish kills by suppressing cardiac 
electrical activity. However, the specific pesticides mancozeb and phorate did not 
demonstrate such dramatic cardiotoxic effects, even at high concentrations. 	   	  
	   VI	  
ACKNOWLEDGEMENTS 
 
I wish to acknowledge my supervisors, Dr. Robert Gilmour and Dr. Etienne Côté, 
for their unconditional encouragements, expertise and intellectual guidance during my 
Master’s research project and cardiology residency. I wish to express to you all my 
admiration and gratitude. 
 
I also wish to acknowledge the members of my supervisory committee, Dr. Cate 
Creighton, Dr. Don Stevens and Dr. Van Den Heuvel for their guidance, valuable 
suggestions, and constructive criticisms thourought my project. 
 
I would like to extend my sincere appreciation to Barry Connell, Monique Saleh, 
Francis Ortega, Madeleine Brûlé and Tyler Dexter for their technical help. Thank you to 
Dr. Elizabeth Cherry for her precious expertise during the analysis of my raw data using 
Matlab, as well as to Dr. Henrik Stryhn for his guidance during the statistical analysis of 
my data.  
 
This project was made possible by financial support from the Natural Sciences and 
Engineering Research Council of Canada.  
 
I also wish to acknowledge my past mentors, Dr. Valérie Chetboul and Dr. David 
Sisson, without whom none of this would have been possible.  
 
Thank you to Elaine Reveler for her sympathetic ear. 
 
Merci à mes parents, Mauricette et Alain, ainsi qu’à Alexandre pour m’avoir 
permis d’aller toujours plus loin. Merci aux fidèles Cayenne (deuxième thèse!), Jalna et 
Mina. Je vous aime tous/toutes très fort.  
 
À mes amis, un peu partout sur cette planète. Mille mercis.  
   
	   VII	  
	   TABLE	  OF	  CONTENTS	   	  
 
Thesis non-exclusive license  ............................................................................................ II 
Certification of thesis work  ........................................................................................... III 
Abstract  ........................................................................................................................... IV 
Acknowledgements  ......................................................................................................... VI 
List of figures  .................................................................................................................. IX 
List of tables  .................................................................................................................... XI 
List of abbreviations  ..................................................................................................... XII 	  
1. General introduction  ..................................................................................................... 1 	  
2. Background and literature review  ............................................................................... 3 
 
2.1. Fish kills in Prince Edward Island (Canada)  .................................................................. 3 
2.1.1. History of fish kills in Prince Edward Island  .......................................................... 3 
2.1.2. Impact on fish populations ..................................................................................... 5 
2.1.3. Public interest and perception of fish kills ............................................................... 5 
2.1.4. The causes of fish kills ........................................................................................... 7 
 
2.2. Cardiac effects of environmental toxicants in fish ......................................................... 14 
2.2.1. Common cardiotoxic environmental pollutants in fish ............................................ 14 
2.2.2. Common cardiac disturbances caused by cardiotoxic environmental pollutants in fish 
 .................................................................................................................................... 14 
2.2.3. The zebrafish as a model to evaluate the cardiac effects of environmental toxicants . 18 	  
2.3. The cardiovascular system in zebrafish (Danio rerio) ................................................... 21 
2.3.1. Cardiac anatomy ................................................................................................. 21 
2.3.2. Histology of the zebrafish heart ............................................................................ 23 
2.3.3. Cardiac action potentials in zebrafish ................................................................... 27 
2.3.4. Ion currents contributing to the action potential .................................................... 29 	   2.3.4.1. Sodium currents  ........................................................................................... 29 
2.3.4.2. Calcium currents  .................................................................................................. 30	  
2.3.4.3. Potassium currents  ............................................................................................... 32	  
2.3.4.4. Other ionic currents  .............................................................................................. 34	  
2.3.5.	  Excitation-contraction coupling ............................................................................ 36 
2.3.6.	  Cardiovascular control: innervation of the zebrafish heart ..................................... 40 	  
3. Materials and methods ................................................................................................ 44 
 
3.1. Animals  .................................................................................................................... 44 
 
	   VIII	  
3.2. Procedures common to all experiments  ....................................................................... 44 	  
3.3. Treatments  ................................................................................................................ 47 
3.3.1. Choice of toxicants to investigate .......................................................................... 48 
3.3.2. Treatments with acetylcholine (treatments 1a, 1b and 1c) ....................................... 49 
3.3.3. Treatment with physostigmine (treatment 2) .......................................................... 50 
3.3.4. Treatment with mancozeb (treatment 3) ................................................................ 51 
3.3.5.	  Treatment with phorate (treatment 4) .................................................................... 51 	  
3.4. Statistical analysis  ..................................................................................................... 52 	  
4. Results ........................................................................................................................... 54 
 
4.1. Treatments with acetylcholine (treatments 1a, 1b and 1c)  ............................................. 54 
 
4.2. Treatment with physostigmine (treatment 2) ................................................................ 58 	  
4.3. Treatment with mancozeb (treatment 3)  ...................................................................... 59 	  
4.4. Treatment with phorate (treatment 4) ........................................................................... 59 	  
4.5. Between-group comparisons of atrial action potential parameters  ................................. 62 	  
5. Discussion  ..................................................................................................................... 65 
 
5.1. Overview of objectives ............................................................................................... 65 	  
5.2. Effects of acetylcholine (treatments 1a, 1b and 1c)  ...................................................... 66 
 
5.3. Effects of physostigmine (treatment 2) ......................................................................... 69 	  
5.4. Effects of mancozeb and phorate (treatments 3 and 4)  .................................................. 71 	  
5.5. Limitations of the study .............................................................................................. 72 	  
6. Conclusion and future directions  ............................................................................... 75 
 
7. References  .................................................................................................................... 77 
	  
8. Annexes: raw data tables  ............................................................................................ 90 	  	   	  
	   IX	  
LIST OF FIGURES 	  
Figure 1. Map of reported fish kills in Prince Edward Island from 1962 to 2011 (DCLE 
2011a) ................................................................................................................................... 4 
Figure 2. Local newspapers discussing fish kills in Prince Edward Island (McCarthy 
2016a, 2016b; Guardian 2016; Yarr 2016) .......................................................................... 6 
Figure 3. 1993-2014 sales of non-domestic pesticides in Prince Edward Island (DCLE 
2015a, 2015b) ..................................................................................................................... 10 
Figure 4. Research areas using zebrafish models (Bournele and Beis 2016) ................... 19 
Figure 5. Anatomy of the adult zebrafish (White et al. 2013) .......................................... 21 
Figure 6. Cardiovascular anatomy of the zebrafish (Hu et al. 2001) ................................ 22 
Figure 7. Ultrastructure of the zebrafish heart (from Hu et al. 2001) ............................... 24 
Figure 8. Photographs of atrial myocytes of zebrafish and human (enzymatically isolated) 
(Verkerk and Remme 2012) ............................................................................................... 25 
Figure 9. Cross section of the bulbus arteriosus showing the three concentric layers ...... 26 
Figure 10. Representative shapes of atrial (left column) and ventricular (right column) 
cardiac action potentials in the adult zebrafish (A), human (B) and mouse (C) (Nemtsas et 
al. 2010) ............................................................................................................................. 28 
Figure 11. Expression of Isl1 and likely location of the functional pacemaker in the adult 
zebrafish heart (Tessadori et al. 2012) ............................................................................... 35 
Figure 12. Schematic diagram of the cardiac sarcomere and of the regulatory complex 
associated with the actin filament responsible for making the contractile reaction 
activated by calcium (Gillis 2011) ..................................................................................... 37 
Figure 13. Calcium handling in the fish cardiomyocyte (Shiels 2011) ............................. 39 
Figure 14. Autonomic cardiac control in teleost fish (Nilsson 2011).  ............................. 41 
Figure 15. Organization of intracardiac nervous system demonstrated with acetylated 
tubulin (AcT) and human neuronal protein (Hu) immuhistochemistry (Stoyek et al. 2015)
 ............................................................................................................................................ 42 
Figure 16. Adult zebrafish heart after explantation from the throracic cavity .................. 45 
Figure 17. Intracellular action potential recording setup  ................................................. 47 
Figure 18. Atrial action potential parameters before and after exposure to acetylcholine 
(1 µM) – treatment 1a (n = 5) ............................................................................................ 55 
Figure 19. Atrial action potential parameters before and after exposure to acetylcholine 
(10 µM) followed by a washing period – treatment 1b (n = 6) .......................................... 56 
Figure 20. Atrial action potential parameters before and after exposure to acetylcholine 
(10 µM) followed by atropine (1 µM) – treatment 1c (n = 4)  ........................................... 57 
	   X	  
Figure 21. Suppression of atrial action potential induced by physostigmine (50 µM) in 
presence of a low concentration of acetylcholine (1 µM) .................................................. 58 
Figure 22. Change in action potential morphology induced by physostigmine (50 µM) in 
presence of a low concentration of acetylcholine (1 µM) .................................................. 58 
Figure 23. Atrial action potential parameters before and after exposure to mancozeb (18.5 
µM ) + acetylcholine (1 µM) – treatment 3 (n = 6)  ........................................................... 60 
Figure 24. Atrial action potential parameters before and after exposure to phorate (38.4 
µM ) + acetylcholine (1 µM) – treatment 4 (n = 6) ............................................................ 61 
Figure 25. Relative change from baseline in action potential duration at 90% 
repolarization (APD 90) ..................................................................................................... 62 
Figure 26. Relative change from baseline in action potential duration at 50% 
repolarization (APD 50) ..................................................................................................... 63 
Figure 27. Relative change from baseline in action potential amplitude (APA) .............. 64 	  
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	   XI	  
LIST OF TABLES 
 
Table 1. Most common causes of fish kills in freshwaters and estuaries (La and Cooke  
2011) .................................................................................................................................... 8 
Table 2. 2013-2014 Non-domestic pesticide sales in Prince Edward Island (DCLE 2015c)
 ............................................................................................................................................ 11 
Table 3. Action potential parameters in atria and ventricles of adult zebrafish as 
compared with human and mouse (Nemtsas et al. 2010) .................................................. 28 
Table 4. Summary of the different treatment protocols .................................................... 51 
Table 5. Mechanisms of action, chemical properties, and structures of the tested 
compounds (INERIS 2017; NCBI 2017)  .......................................................................... 52 
Table 6. Atrial action potential parameters before and after exposure to acetylcholine (1 
µM) – treatment 1a (n = 5)  ................................................................................................ 55 
Table 7. Atrial action potential parameters before and after exposure to acetylcholine (10 
µM) followed by a washing period – treatment 1b (n = 6) ................................................ 56 
Table 8. Atrial action potential parameters before and after exposure to acetylcholine (10 
µM) followed by atropine (1 µM) – treatment 1c (n = 4) .................................................. 57 
Table 9. Atrial action potential parameters at baseline – treatment 2 (physostigmine) (n = 
5)  ....................................................................................................................................... 59 
Table 10. Atrial action potential parameters before and after exposure to mancozeb (18.5 
µM ) + acetylcholine (1 µM) – treatment 3 (n = 6) ............................................................ 60 
Table 11. Atrial action potential parameters before and after exposure to phorate (38.4 
µM ) + acetylcholine (1 µM) – treatment 4 (n = 6)  ........................................................... 61 
 
  
	   XII	  
LIST OF ABBREVIATIONS 
 
ACh: acetylcholine 
AChE: acetylcholinesterase  
AChEI: acetylcholinesterase inhibitor 
AcT: acetylated tubulin 
ANOVA: analysis of variance 
APA: action potential amplitude  
APD: action potential duration 
Ba2+: barium ion 
Ca2+: calcium ion 
CCAC: Canadian Council on Animal Care 
ChaT: choline acetyltransferase 
cTn: cardiac troponin 
cTnC: cardiac troponin C  
cTnI: cardiac troponin I  
cTnT: cardiac troponin T  
hpf: hours post fertilization 
Hu: human neuronal protein  
ICa: calcium current 
ICaL: L-type calcium current 
ICaT: T-type calcium current 
If or Ih: pacemaker current 
IK,ACh: acetylcholine-sensitive inward rectifier potassium current 
IK,ATP: ATP-sensitive inward rectifier potassium current 
IK1: inward rectifier potassium current 
IKr: rapid delayed rectifier potassium current 
IKs: slow delayed rectifier potassium current 
INa: sodium current 
K+: potassium ion 
M2R: muscarinic cholinergic type 2 receptor 
Na+: sodium ion 
NCX: Na+- Ca2+ exchanger 
Ni2+: nickel ion 
PAH: polycyclic aromatic hydrocarbon 
PBDE: polybrominated diphenyl ether 
PEI: Prince Edward Island, Canada 
SERCA: ATP-dependant Ca2+ uptake pump of the sarcoplasmic reticulum 
TMS: tricainemethanosulfonate 
VAChT: vesicular acetylcholine transporter  
	   1	  
1. General introduction 
 
On average, there has been more than one documented fish kill per year in Prince 
Edward Island (PEI), Canada, over the past 50 years (DCLE 2011a, 2011b, 2015d, 2015e; 
Johnston and Cheverie 1980; Macphail 2013). This increasing concern with fish kills in 
PEI is associated with an increase in the use of environmental toxicants, including 
agricultural pesticides (DCLE 2015a, 2015b). A causal relationship between the use of 
pesticides and fish kills has been challenging to demonstrate, and necropsies performed 
on dead fish are often unremarkable. In this project, I hypothesized that fish exposure to 
selected environmental toxicants leads to increased mortality and morbidity by depressing 
cardiac hemodynamic function precipitated by cardiac rhythm disturbances. These 
rhythm disturbances likely result from toxicant-induced changes in the function of 
specific ion channels. 
 
The rationale for this project derives from several recent studies that have 
demonstrated that exposure to several environmental toxicants leads to abnormal cardiac 
development and/or abnormal cardiac function. These environmental toxicants include 
dioxins (Antkiewicz et al. 2006; Scott et al. 2011; Plavicki et al. 2013; Brown et al. 2015, 
2016a), polybrominated diphenyl ethers (PBDEs) (Lema et al. 2007), crude oil 
constituents such as polycyclic aromatic hydrocarbons (PAHs) (Incardona et al. 2004; 
Incardona et al. 2005; Incardona et al. 2009; Hicken et al. 2011; Jung et al. 2013; Brette et 
al. 2014; Incardona et al. 2014; Raimondo et al. 2014; Brown et al. 2015; Edmunds et al. 
2015; Gerger and Weber 2015; Incardona et al. 2015; Brown et al. 2016a), or pesticides 
containing  acetylcholinesterase inhibitors (AChEIs) (Lin et al. 2007; Jee et al. 2009; 
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Tryfonos et al. 2009; Simoneschi et al. 2014; Watson et al. 2014; Du et al. 2015; Pamanji 
et al. 2015). More specifically, heart rhythm disorders ranging from bradyarrhythmias to 
tachyarrhythmias have the potential to decrease cardiac output, which at best could have 
consequences on growth rates or swimming speed and at worst could lead to fish 
mortality (Gerger and Weber 2015). The electrophysiological mechanisms responsible for 
these rhythm disturbances rarely have been explored. Given the substantial impact of 
environmental toxicants on fish health and possibly on the economics of the fishing 
industry, identifying these mechanisms could lead to improved preventive strategies and 
regulations.  
 
In order to contribute to a better understanding of this problem, I investigated the 
effects of selective environmental toxicants, including the commonly used AChEIs, on 
cardiac action potential morphology using standard microelectrode techniques in adult 
zebrafish (Dano rerio). The first part of my thesis will focus on providing an overview on 
fish kills in PEI, followed by an assessment of the possible cardiac dysfunctions caused 
by environmental toxicants in fish, before exploring the cardiac specificities of zebrafish 
used as models. 
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2. Background and literature review 
 
2.1. Fish kills in Prince Edward Island (Canada) 
 
2.1.1. History of fish kills in Prince Edward Island 
 
Fish kills are defined as localized mass die-offs of fish that can occur in marine, 
estuarine, or fresh waters (Meyer and Barclay 1990). The first reported fish kill in PEI 
occurred in 1962 after accidental spillage of the agricultural fungicide nabam (disodium 
ethylene bisdithiocarbamate) and the insecticide endrin, a chlorinated hydrocarbon, into 
Mill River (Saunders 1969). Extensive mortalities, including a total of at least 8000 fish, 
were observed among brook trout (Salvelinus fontinalis) and juvenile Atlantic salmon 
(Salmo salar). Since that time, fish kills have become a chronic issue throughout the 
province of PEI, with 51 fish kills reported between 1962 and 2011 (Figure 1) (DCLE 
2011a, 2011b, 2015d, 2015e; Johnston and Cheverie 1980; Macphail 2013). 
	   4	  
 
Figure 1. Map of reported fish kills in Prince Edward Island from 1962 to 2011 
(DCLE 2011a). 
 
Fish kills typically occur between June and September, with a peak between July 
19th and July 25th (DCLE 2011b; Macphail 2013). The two worst years for reported fish 
kills were 1999 and 2002 with eight fish kills per season (DCLE 2011b; Macphail 2013). 
Fish kills often occur in cultivated watersheds where pesticide applications are likely, and 
following rainfalls, suggesting pesticide wash-off as a likely cause (Mutch 2002; Birt 
2007; Gordon et al. 2011; Bauer et al. 2013; Dunn et al. 2011).  
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2.1.2. Impact on fish populations 
 
It has been demonstrated that different species of fish have variable responses to 
toxicant exposure (Post and Leasure 1974; Gormley et al. 2005; Guignion et al. 2010), 
which can lead to changes in fish communities over time (Gormley et al. 2005, Bauer et 
al. 2013). For example, Gormley et al. (2005) showed that brook trout (Salvelinus 
fontinalis) suffered higher mortality than rainbow trout (Oncorhynchus mykiss) 
immediately after runoff events involving the pesticide azinphos-methyl, an 
organophosphate, on the Wilmot River, PEI, in 2002. Similarly, within the same species, 
susceptibility to certain toxicants can vary with fish life stages (Van Leeuwen et al. 1985; 
Gormley et al. 2005). During the 2002 Wilmot River events, young-of-the-year fish were 
more susceptible than older age classes. Most interestingly, new sampling performed a 
year after the events, revealed fish communities that were still skewed in terms of the 
proportions of species and the proportions of age classes (Gormley et al. 2005), 
highlighting the long-term consequences of fish kills on fish populations. 
 
2.1.3. Public interest and perception of fish kills 
 
There has been an increase in public awareness regarding fish kills over the years, 
with an increased demand for determining their cause and reducing their occurrence (La 
and Cooke 2011). Over the past several years, fish kills have been extensively discussed 
in the media in PEI, including major local newspapers (Figure 2) (McCarthy 2016a, 
2016b; Guardian 2016; Yarr 2016). 
.  
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Figure 2. Local newspapers discussing fish kills in Prince Edward Island (McCarthy 
2016a, 2016b; Guardian 2016; Yarr 2016). 
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Fish kills are highly visible to the public and may be signs of detrimental 
environmental changes (Holck et al. 1993, La and Cooke 2011). Moreover, they may be 
seen as precursors for future human illnesses. In addition, when it is demonstrated that 
fish kills have been caused by the release of toxicants such as pesticides, civil and or 
criminal penalties may be levied against individuals or groups determined to be 
responsible for the release (Holck et al. 1993). This was the case of a potato farmer in PEI 
fined $70,000 in connection with a fish kill that occurred in 2011 in a Prince County 
waterway (Environment Canada 2014). Fish kills may also have political consequences 
and are increasingly discussed during political campaigns in PEI (NDP PEI 2013). 
Recently, a petition was mounted by environmental groups to criticize the appointment to 
the board of Health PEI of two members of the potato industry (Campbell 2016). 
 
2.1.4. The causes of fish kills 
 
Although fish kills sometimes can be attributed to natural phenomena, they are 
most commonly caused by human modifications and pollution of the environment (Table 
1) (La and Cooke 2011). In a study analyzing 170 fish kill events in North American 
freshwaters and estuaries, the major proximate causes of fish kills were agricultural 
pollution (19.5%), biotoxins (17.2%), and chemical pollution (7.1%) (La and Cooke 
2011). Minor causes were extreme changes in temperatures (5.9%), low dissolved oxygen 
(5.3%), gas bubble trauma (3.6%), disease (3.6%), exhaustion (2.4%), and acidification 
(1.2%). Notably, the majority of surveyed fish kills were caused by human activities 
(67%), while natural events were only responsible for 10% (La and Cooke 2011). 
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Table 1. Most common causes of fish kills in freshwaters and estuaries (La and 
Cooke 2011). 
 
Cause Definition 
Agricultural pollution Pollution that pertains to pesticide, fertilizer and manure, silo 
and feedlot drainage, animal waste, etc. Can be direct or lead 
to other problems, such as hypoxia, as a result of biological 
oxygen demand 
 
Acidification Acidification by oxidation of sulphide minerals; can be 
delivered via precipitation (e.g., acid rain) 
 
Biotoxin Toxic algal and dinoflagellate blooms that are caused by 
Karena brevis, Pfiestera, etc. 
 
Disease Various bacteria, parasites, fungus, and viruses 
 
Exhaustion Physical exhaustion of fish typically leading to cardiac 
collapse (e.g., during challenging migration) 
 
Extreme temperature 
changes 
Rapid changes in temperature (e.g., cold shock) 
 
 
Gas bubble trauma Gas-supersaturation downstream from dams or other 
infrastructure or natural barriers 
 
Industrial pollution Pollution arising from various resource extraction, processing, 
and manufacturing activities (e.g., mining, food and kindred 
products, chemicals, metals, petroleum, and paper products) 
 
Low dissolved oxygen 
(hypoxia) 
Low levels of oxygen in the water, usually associated with 
urban runoff, decay of organic material (i.e., biological 
oxygen demand), rainfall events, etc. 
 
Municipal pollution Pollution arising from refuse disposal, water system, 
swimming pools, power, and sewage systems 
 
Transportation pollution Pollution that pertains to rail, trucks, barge or boats, and 
pipeline ruptures 
 
Unknown/undetermined Fish kill events in which no cause can readily be determined 
 
In PEI, at least 30 out of 51 reported fish kills were likely caused by agricultural 
pollution (pesticides) between 1962 and 2011 (DCLE 2001b). Potatoes are the single 
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most common agricultural commodity in PEI in terms of farm cash receipts, and their 
intensive production may play a role in fish kills. Approximately 89,500 acres of potatoes 
were planted in 2015 (DAF 2015). Over the last five years farm cash receipts values have 
ranged from $203 to $257 million (DAF 2015). Intense production systems are used 
including monoculture row production (Chow et al. 1990), intensive tillage, cultivation 
along slopes, and limited rotations (Edwards et al. 2000; Jatoe et al. 2008). PEI soil types 
are particularly suitable for potato production: sandy loams on PEI have moderately high 
silt content and are well drained. However, these types of soil are also vulnerable to 
erosion and pesticide wash-offs during heavy rainfalls (Jatoe et al. 2008). In addition, the 
use of pesticides in agriculture has significantly increased over the 10 past years, with 
pesticide sales reaching more than a million kilograms in 2013 and 2014 (Figure 3) 
(DCLE 2015a, 2015b). More than 50 different pesticides are used, including mostly 
fungicides commonly used on potato crops (Table 2) (DCLE 2015c). AChEIs are 
commonly used, including carbamates such as mancozeb, or organophosphates such as 
phorate (DCLE 2015c). 
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Figure 3. 1993-2014 sales of non-domestic pesticides in Prince Edward Island (DCLE 2015a, 2015b). 
Others: this includes combination products (i.e. insecticide / fungicide), rodenticides, animal and bird repellents, disinfectant, and preservatives. Only reported in 
2013 and 2014.   
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Others 0 0 0 0 0 0 0 0 0 0 0 0 15574 19758 
Herbicides 104000 103000 101900 106789 105039 119945 129552 119951 111237 82526 82515 96004 158114 161536 
Fungicides 390000 515000 893600 680764 722502 848340 899658 622538 667862 605829 517158 556768 766805 647627 
Insecticides 108000 88000 58400 63346 58677 86220 60899 43489 35004 48032 30609 27779 222124 190376 
0 
200000 
400000 
600000 
800000 
1000000 
1200000 
1400000 
K
ilo
gr
am
 o
f a
ct
iv
e 
in
gr
ed
ie
nt
s 
Annual sales for non-domestic pesticides 
	   11	  
Table 2. 2013-2014 Non-domestic pesticide sales in Prince Edward Island (DCLE 
2015c). 
 
Active Ingredient Amount Sold 
(kilograms) 
2013 2014 
2,4-D 1 605 1 844 
atrazine 2 114 2 870 
azoxystrobin 1 229 1 952 
boscalid 1 822 1 771 
captan 1 640 1 040 
carbathiin 1 083 2 319 
chlorantraniliprole 1 187 1 382 
chlorothalonil 141 457 140 491 
chlorpropham 531 1 028 
chlorpyrifos 788 741 
clethodim 804 834 
clothianidin 879 1 322 
copper hydroxide 1 647 1 423 
cymoxanil 197 536 
diazinon 455 247 
dimethoate 4 296 2 376 
diquat 16 284 22 409 
fenamidone 1 179 816 
flonicamid 1 202 1 138 
fluazifop-p-butyl 813 711 
fluazinam 616 1 596 
fludioxonil 567 693 
glyphosate 52 351 57 696 
hexazinone 6 619 7 627 
imidacloprid 3 453 3 919 
linuron 31 625 27 528 
maleic hydrazide 5 122 3 700 
mancozeb 424 457 303 957 
mandipropamid 748 1 380 
MCPA 21 442 18 361 
metalaxyl-M and S-isomer 2 014 1 982 
metiram 43 565 39 535 
s-metolachlor 2 994 2 249 
metribuzin 6 284 9 528 
mineral oil 175 987 140 961 
mono- and di-basic sodium, potassium, and ammonium 
phosphites 
5 810 7 749 
mono- and di-potassium phosphite 124 992 124 733 
phorate 21 945 27 557 
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Table 2 (continued). 2013-2014 Non-domestic pesticide sales in Prince Edward 
Island (DCLE 2015c). 	  
phosmet 8 222 6 796 
propiconazole 1 892 1 591 
propyzamide 1 621 1 673 
pyraclostrobin 2 084 1 981 
rimsulfuron 4 600 276 
surfactant blend 8 264 12 617 
terbacil 1 652 2 025 
thiabendazole 865 604 
thiophanate-methyl 5 184 5 988 
thiram 965 2 060 
tribenuron-methyl 1 218 42 
trifuralin 1 021 944 
all other active ingredients 13 226 14 699 
TOTAL 1 162 617 1 019 297 
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Although many fish kills are suspected to be caused by agricultural pollution, 
establishing a causal relationship between fish kills and pesticides remains challenging 
for several reasons (Holck et al. 1993; Muñoz et al. 1994; Mutch 2002; La and Cooke 
2011; DCLE 2015d, 2015e): 1) The unpredictable nature of fish kills limits the amount of 
control that can be exercised over sampling locations, timing and procedures used for 
investigation. 2) There is often a substantial delay between pesticide wash off into a 
stream after a rainfall event, and first notice of the resulting impacts on fish (from two 
hours to as much as a week). 3) Pathology results are often inconclusive due to advanced 
tissue decomposition or absence of visible lesions. 4) Pesticides can be flushed from the 
stream water by the time sampling can be initiated (especially with the short length of PEI 
streams). 5) In cases where one or several pesticides can be identified, the exact 
mechanism by which they lead to a fish kill is often unknown. 6) Fish kills are often 
multifactorial in origin (for example, specific conditions including the presence of a 
pesticide, water oxygen level, or water temperature may have synergistic effects).  
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2.2. Cardiac effects of environmental toxicants in fish 
 
2.2.1. Common cardiotoxic environmental pollutants in fish 
 
The majority of fish kills are caused by human activities including agricultural, 
industrial, municipal and transportation-related activities (La and Cooke 2011). Over the 
recent years, several environmental toxicants have shown to be associated with abnormal 
cardiac function in fish including dioxins (Antkiewicz et al. 2006; Scott et al. 2011; 
Plavicki et al. 2013; Brown et al. 2015, 2016a), PBDEs (Lema et al. 2007), crude oil 
constituants such as PAHs (Incardona et al. 2004; Incardona et al. 2005; Incardona et al. 
2009; Hicken et al. 2011; Jung et al. 2013; Brette et al. 2014; Incardona et al. 2014; 
Raimondo et al. 2014; Brown et al. 2015; Edmunds et al. 2015; Gerger and Weber 2015; 
Incardona et al. 2015; Brown et al. 2016a), and pesticides including AChEIs (Lin et al. 
2007; Jee et al. 2009; Tryfonos et al. 2009; Simoneschi et al. 2014; Watson et al. 2014; 
Du et al. 2015; Pamanji et al. 2015). 
 
2.2.2. Common cardiac disturbances caused by cardiotoxic environmental pollutants in 
fish  
 
The exact mechanisms by which pollutants are causing fish kills often remain 
unknown (La and Cooke 2011). However, based on the existing knowledge, it can be 
speculated that selected environmental toxicants lead to fish kills by depressing cardiac 
hemodynamic function, which can be the result of cardiac developmental abnormalities, 
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cardiac rhythm disturbances, impaired myocardial excitation-contraction coupling, or 
impaired myocardial contractility or relaxation. 
 
Developmental abnormalities may include altered cardiac looping as seen in 
zebrafish exposed to dioxins (Antkiewicz et al. 2006), PAHs (Jung et al. 2013) or 
organophosphates (Pamanji et al. 2014; Du et al. 2015), as well as in mahi mahi 
(Coryphaena hippurus) exposed to PAHs (Edmunds et al. 2015). Abnormal epicardial 
development has been demonstrated in zebrafish exposed to dioxins, and abnormal 
myocardial development has been demonstrated in zebrafish exposed to PAHs or 
organophosphates (Scott et al. 2011; Du et al. 2015; Incardona et al. 2015). For example, 
the study from Incordona et al. (2015) revealed the development of an abnormally 
hypertrophic spongy myocardium. These morphological abnormalities are often 
associated with altered cardiac function manifested as decreased myocardial contractility 
and/or signs of congestive heart failure. Pericardial edema is often identified as a 
cardiotoxic effect in fish (Scott et al. 2011; Incardona et al. 2014; Pamanji et al. 2014; 
Raimondo et al. 2014; Watson et al. 2014; Brown et al. 2015; Edmunds et al. 2015). 
 
Cardiac rhythm disturbances associated with acute exposure to environmental 
toxicants include asystole, 2nd degree (intermittent) atrioventricular conduction block and 
supraventricular or ventricular tachyarrhythmias. Ventricular asystole or standstill was 
reported in zebrafish larvae exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and 
manifested as a beating atrium and a complete loss of visible ventricular contraction 
(Antkiewicz et al. 2006). However, no electrophysiological study was performed to 
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determine if asystole was caused by complete atrioventricular block with no ventricular 
escape rhythm or by ventricular inexcitability. Sinus node arrest in the absence of 
subsidiary pacemaker activity could also explain asystole, but in this case the atrium 
would also not be contracting. Asystole leads to complete cessation of blood flow to vital 
organs and subsequent death. 
 
Second-degree atrioventricular block occurs when one or more atrial impulses 
fail(s) to conduct to the ventricles due to impaired atrioventricular electrical conduction. 
This type of block leads to decreased cardiac output and potentially insufficient perfusion 
of vital organs, especially when the fish is active. 2:1 atrioventricular block (every other 
atrial electrical impulse is being blocked from conducting to the ventricles) was observed 
in zebrafish embryos exposed to PAHs (Incardona et al. 2004). In this case too, the exact 
electrophysiological mechanism was not described and diagnosis was suspected based on 
direct visualization of the heart in zebrafish embryos that are nearly transparent. Lema et 
al. (2007) also observed 4:1, 5:1 and 8:1 2nd degree atrioventricular block in zebrafish 
embryos exposed to different concentrations of PBDE. 
 
Tachyarrhythmias, either supraventricular or ventricular, have been observed 
experimentally in zebrafish embryos exposed to PBDE (Lema et al. 2007), as well as in 
large predatory pelagic fish after the Deepwater Horizon disaster released more than 636 
million liters of crude oil into the northern Gulf of Mexico. Tachyarrhythmias also lead to 
decreased cardiac output secondary to decreased cardiac chamber filling time. Again, the 
electrophysiological mechanisms of these tachyarrhythmias were not described in most of 
these studies, but may include abnormal automaticity or early afterdepolarization-induced 
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triggered activity or re-entry (Gilmour 2015). One study demonstrated that crude oil 
(PAHs) can cause prolongation of the action potential by blocking the delayed rectifier 
potassium current IKr in juvenile bluefin and yellowfin tuna, which predisposes to 
afterdepolarization-induced triggered activity (Brette et al. 2014).  
 
Bradycardia is often encountered in fish exposed to pesticides containing AChEIs 
(Lin et al. 2007; Simoneschi et al. 2014; Watson et al. 2014). However, as for other 
arrhythmias, the electrophysiological mechanisms responsible for bradycardia rarely have 
been explored. Abramochkin et al. (2012) studied the effects of the organophosphorous 
AChEI paraoxon, active metabolite of the insecticide parathion, on different 
electrophysiological parameters, including action potential duration, on isolated atrial and 
ventricular myocardium preparations of cod. Incubation of isolated atrium with paraoxon 
caused significant reduction of action potential duration (which can result in decreased 
contractility) and marked slowing of sinus rhythm. These effects likely cause a serious 
decrease in cardiac output in vivo and, secondarily, death.  
 
One study specifically highlighted the occurrence of altered excitation-contraction 
coupling due to the reduction of calcium (Ca2+) transients through the sarcolemma and 
sarcoplasmic reticulum of ventricular cardiomyocytes in juvenile bluefin and yellowfin 
tuna exposed to crude oil samples obtained from the Deepwater Horizon disaster 
previously mentioned (Brette et al. 2014). 
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2.2.3. The zebrafish as a model to evaluate the cardiac effects of environmental 
toxicants 
 
Over the past decade, the zebrafish has been increasingly used as a research model 
for studies of human cardiac development and electrophysiology, as well as for cardiac 
toxicological studies (Figure 4) (Arnaout et al. 2007; Ververk and Remme 2012; 
Bournele and Beis 2016; Brown et al. 2016b; Genge et al. 2016; Sarmah and Marrs 
2016). Zebrafish provide several advantages over other vertebrates, such as low cost, 
small size, easy handling and maintenance, high fecundity, rapid development outside the 
mother’s body, and well-characterized cardiogenesis stages easily visualized through the 
transparent embryos or larvae (Ververk and Remme 2012; Sarmah and Marrs 2016). 
Moreover, the zebrafish genome has been fully sequenced, and approximately 71% of 
human genes have at least one ortholog in the zebrafish genome (Postlethwait et al. 1998; 
Howe et al. 2013; Vornanen and Hassinen 2016). The zebrafish also has a remarkable 
cardiac regenerative capacity, which makes it a valuable model to study myocardial 
regeneration after infarction, the leading cause of death worldwide (Kikuchi 2014; 
Kikuchi 2015; WHO 2017). 
 
The main disadvantage of the zebrafish as a research model for cardiovascular 
development and disease is that the heart is extremely small (see section 2.3.1.), making 
pressure and cardiac output measurements particularly challenging (Genge et al. 2016). 
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Figure 4. Research areas using zebrafish models (Bournele and Beis 2016). SNP: 
single-nucleotide polymorphism. With permission of Springer. 
 
Until recently, mice have been predominantly used for the investigation of 
electrophysiological conditions in humans. However, mice have several limitations for 
modeling cardiovascular disease, including a fast basal heart rate, a large phase-1 
repolarization phase and a short action potential (Ververk and Remme 2012). Despite 
being coldblooded and having a two-chamber heart morphology, the zebrafish has a heart 
rate and action potential shape and duration that more closely resemble those of humans 
(See section 2.3.3.). Over the recent past, the zebrafish has been increasingly used as a 
model to investigate channelopathies, especially human IKr channel-related disease, 
including long QT syndrome (Ververk and Remme 2012). 
 
In toxicology, the zebrafish has been very useful in investigating chemical toxicity 
during prenatal development; heart rate can be counted and cardiac edema can be easily 
visualized in transparent developing embryos with a simple dissecting microscope, and 
more advanced imaging techniques can be used to study cardiac developmental defects 
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(Sarmah and Marrs 2016). The zebrafish embryo has been used to assess the impact of 
exposure to environmental pollutants including dioxins, PAHs, PBDEs, AChEIs (see 
section 2.2.2.), but also exposure to nanoparticles (Chakraborty et al. 2016), alcohol 
(Dlugos and Rabin 2010; Sarmah and Marrs 2016), recreational drugs such as cocaine 
(Mersereau et al. 2015), or cigarette smoke (Ellis et al. 2014). 
 
Many fewer studies have used juvenile or adult zebrafish in toxicology, compared 
with embryos or larvae (Sarmah and Marrs 2016). The effects of cocaine on the heart rate 
of adult zebrafish have been evaluated using electrocardiography (Mersereau et al. 2015). 
Recently, Gerger and Weber (2015) determined the acute effects on ventricular rate in 
adult zebrafish of exposure to the PAH, benzo-a-pyrene, by intraperitoneal injection or 
simple aqueous contact. While electrophysiological data have been obtained in adult 
zebrafish using standard intracellular microelectrode or patch clamp techniques, no study 
has been performed to date to evaluate the effects of environmental pollutants on 
electrophysiological parameters in this species. Thus, there is an opportunity for further 
research using the adult zebrafish as a model in toxicology. 
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2.3.The cardiovascular system in zebrafish (Danio rerio) 
 
2.3.1. Cardiac anatomy 
 
Cardiac anatomy varies considerably among fish species, depending on body 
morphology and physiology (Santer 1985). In zebrafish, the heart is located 
anteroventrally to the thoracic cavity between the operculum and the pectoral girdles 
(Figure 5) (Hu et al 2001; Farrell and Pieperhoff 2011).  The heart is contained in a silver-
coloured membranous sac, the pericardium. More specifically, within the pericardium, 
there are four distinct chambers that comprise the heart: the sinus venosus, the atrium, the 
ventricle, and an outflow tract, called the bulbus arteriosus (Figure 6). However, the fish 
heart is often referred to as being two-chambered, with one atrium and one ventricle (Hu 
et al 2001). 
 
	  
Figure 5. Anatomy of the adult zebrafish (White et al. 2013). 
With permission of Macmillan Ltd.	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Figure	  6.	  Cardiovascular	  anatomy	  of	  the	  zebrafish	  (Hu	  et	  al.	  2001).	  	  With	  permission	  of	  John	  Wiley	  and	  Sons.	  
 
Blood returns to the heart from the ductus of Cuvier (which receives blood from 
anterior and posterior cardinal veins and lies outside the pericardium), and from hepatic 
portal veins, which opens directly into the sinus venosus (Hu et al 2001; Farrell and 
Pieperhoff 2011).  The sinus venosus is directly connected to the single-chambered 
atrium, which lies dorsal to the ventricle, via the sino-atrial canal. The sino-atrial canal 
has a one-way ostial valve, which prevents blood from back-flowing into the sinus 
venosus when the atrium contracts (Farrell and Pieperhoff 2011). The atrium is then 
connected to the single-chambered ventricle via the atrioventricular orifice and valve (Hu 
et al 2001). The atrioventricular orifice is positioned on the dorsal and anterior portion of 
the ventricle, adjacent to the bulbus arteriosus. The atrioventricular valve has four distinct 
leaflets oriented anterior, posterior, left, and right of the atrioventricular orifice. Finally, 
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the pyramidal ventricle pumps blood through the bulboventricular orifice into a pear-
shaped bulbus arteriosus (Hu et al 2001). The bulboventricular valve is located at the 
anterior portion of the ventricle and has two semilunar valve cusps, one right and one left. 
The bulbus arteriosus is connected to the ventral aorta, which lies outside the pericardium 
and provides blood to the gill vasculature (Hu et al 2001; Farrell and Pieperhoff 2011). 
 
The zebrafish heart is relatively small. The length of the ventricle is approximately 
1 mm in the adult zebrafish, or 4.28% of the body length (Singleman and Holtzman 
2012).  
 
2.3.2. Histology of the zebrafish heart 
 
All cardiac chambers are lined internally with endothelial cells, forming the 
endocardium. The external surface of the heart has a layer of epithelial cells and 
connective tissue called the epicardium, which represents the inner part (infolding) of the 
pericardium.  The cardiac muscle (myocardium) lies between the endocardial and 
epicardial layers. 
 
The atrium of the zebrafish has a thin wall (two to three cell layers) and shows an 
extensive network of pectinate muscles, which are heavily branched (Figure 7) (Hu et al. 
2001). In the ventricle, cardiac muscle is composed of a relatively thin compact layer 
(three to four cells thick) and an extensive spongy network of muscular trabeculae, which 
account for the greater proportion of ventricular mass (Figure 7) (Hu et al. 2000, 2001).  
A network of coronary vessels is present on the epicardial surface of the ventricle and 
	   24	  
penetrates the compact layer to terminate at the subtrabecular layer level (Hu et al. 2000, 
2001). The trabeculae lack a coronary supply, and likely receive oxygen and nutrients via 
diffusion from blood present in the ventricular cavity (Hu et al. 2001). 
 
  
Figure 7. Ultrastructure of the zebrafish heart (from Hu et al. 2001). A: Scanning 
electron microscopic image of the sagittal section of the left half of a 3 months postfertilization zebrafish 
heart depicting the atrium (A), ventricle (V), bulbus arteriosus (BA), and a portion of the smooth-walled 
ventral aorta (VAo). The asterisk indicates the bulboventricular valve. The arrowhead identifies one of the 
elevated ridges along the inner surface of the bulbar wall. The boxed area on the left side corresponds to B; 
the right box corresponds to C. tr: trabeculae; trf: trabecular fold; pm: pectinate muscle. B: Arrowheads 
point to the coronary vessels, which penetrate into the compact layer (Co) of the ventricular wall. tr: 
trabeculae. C: Arrowheads point to the trabecular bands that act as pillars supporting the leaflet of the 
atrioventricular valve (AV) to prevent retrograde flow. Scale bar = 100 µm in A, 40 µm in B,C. With	  permission	  of	  John	  Wiley	  and	  Sons.	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Cardiomyocytes are relatively small and rod-shaped in zebrafish, with ventricular 
myocytes being larger than those found in the atrium (Hu et al. 2001).  Freshly isolated 
ventricular myocytes from adult zebrafish are approximately 100 x 5 x 6 µm in size 
(lengh x width x height; Brette et al. 2008) and are very narrow compared with human 
ventricular myocytes (Figure 8) (Verkerk and Remme 2012). Myofibrils occupy more 
than half of the atrial and ventricular myocytes, and are centrally located in the cell, with 
abundant mitochondria in the periphery (Hu et al. 2001). Sarcoplasmic reticulum is sparse 
in the zebrafish ventricle, and there is no T-tubule system (Hu et al. 2001).  
 
  
Figure 8. Photographs of atrial myocytes of zebrafish and human (enzymatically 
isolated) (Verkerk and Remme 2012). Notice the narrow shape of the zebrafish atrial myocyte. 
 
The distensible bulbus arteriosus has three distinct layers: externa (outer layer), 
media (middle layer) and intima (inner layer) (Figure 9) (Hu et al. 2001). The intima is 
composed of a subendothelium overlying a thin endothelial layer. The media is composed 
of seven to ten layers of helically arranged smooth muscle cells surrounded by a fine 
network of collagen and reticular and elastic fibrils. The externa is composed of the 
external elastic lamina.  
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Figure 9. Cross section of the bulbus arteriosus showing the three concentric layers 
(Hu et al. 2001). The three successive concentric layers of the bulbous arteriosus are marked by line 
bars. EL: endothelial layer. Arrowheads: ridges separating the luminal surface. bc: nucleated red blood cell. 
Hematoxylin-eosin staining. Scale bar 20 µm. With	  permission	  of	  John	  Wiley	  and	  Sons.	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2.3.3. Cardiac action potentials in zebrafish 
 
Adult zebrafish action potential recordings have been reported for isolated 
ventricular cardiomyocytes using the patch clamp technique (Brette et al. 2008), as well 
as for intact atria and ventricles using a standard intracellular microelectrode technique 
(Nemtsas et al. 2010). These studies showed that the zebrafish adult cardiomyocytes have 
a resting membrane potential of approximately -70 mV and that all phases (0-4) of the 
cardiac action potential are present in the zebrafish heart, except the rapid phase-1 
repolarization (“spike”). Zebrafish action potentials have a rapid upstroke, followed by a 
long lasting plateau phase and a rapid terminal repolarization phase (Figure 10). The 
plateau phase is shorter in atrial than in ventricular tissue. This type of morphology is 
relatively similar to the one found in large mammals such as humans, except for the 
absence of phase 1 (Brette et al. 2008; Nemtsas et al. 2010; Verkerk and Remme 2012; 
Alday et al. 2014, Vornanen and Hassinen 2016). Action potential morphology is 
typically characterized by its duration at different levels of repolarization such as 50% or 
90% (APD 50 or APD 90), its amplitude (APA) and the slope of phase 0, which 
represents the maximum rate of voltage change (dV/dtmax). Average action potential 
parameters measured with sharp microelectrodes in the intact adult zebrafish heart at a 
physiologic temperature of 28°C are summarized in Table 3 (Nemtsas et al. 2010). The 
adult zebrafish spontaneous heart rate (149 ± 8 bpm) is much closer to the human 
spontaneous heart rate (60-100 bpm) than to the mouse spontaneous heart rate (300-600 
bpm) (Nemtsas et al. 2010; Bournele and Beis 2016). 
	   28	  
  
Figure 10. Representative shapes of atrial (left column) and ventricular (right 
column) cardiac action potentials in the adult zebrafish (A), human (B) and mouse 
(C) (Nemtsas et al. 2010). Action potentials were recorded from spontaneously beating (149 ± 8 bpm) 
intact zebrafish hearts at 28 °C, while human and mouse cardiac tissues were stimulated at a frequency of 1 
Hz and measured at 37 °C. Zebrafish recordings were obtained from the apical half of the ventricle and 
from the central area of the atrium. Note that the induced heart rate used for the mouse is substantially 
lower than the spontaneous heart rate in this species, which influences action potential morphology.	  With	  permission	  of	  Elsevier.	  
 
Table 3. Action potential parameters in atria and ventricles of adult zebrafish as 
compared with human and mouse (Nemtsas et al. 2010). 
 Atrium  Ventricle 
 Zebrafish Human Mouse  Zebrafish Human Mouse 
n (preparations) 16 28 7  16 5 6 
APA (mV) 100 ± 2 97 ± 2 104 ± 1  99 ± 2 101 ± 4 95 ± 2 
RMP (mV) -74 ± 2 -74 ± 1 -81 ± 2  -72 ± 2 -77 ± 3 -74 ± 1 
dV/dtmax (V/s) 129 ± 9 246 ± 22 239 ± 10  92 ± 5 180 ± 10 166 ± 11 
APD 20 (ms) 29 ± 2 9 ± 2 3 ± 0  69 ± 3 98 ± 5 4 ± 1 
APD 50 (ms) 46 ± 2 148 ± 8 9 ± 1  110 ± 4 165 ± 12 9 ± 3 
AP 90 (ms) 62 ± 2 316 ± 7 42 ± 4  132 ± 4 242 ± 15 82 ± 4 
Action potentials were measured with sharp microelectrodes in intact zebrafish hearts, mouse left atrial 
trabeculae and right ventricular muscle strips, human right atrial appendage trabeculae and right ventricular 
papillary muscles. Recordings were obtained from the apical half of zebrafish ventricles and the central area 
of atria. Zebrafish hearts were beating spontaneously at 149 ± 8 bpm and kept at 28 °C, while human and 
mouse tissues were electrically stimulated at 1 Hz and kept at 37 °C. APA, action potential amplitude; 
RMP, resting membrane potential; dV/dtmax, maximum depolarization velocity; APD 20, APD 50 and APD 
90, action potential duration measured at 20%, 50% and 90% of repolarization, respectively. With	  permission	  of	  Elsevier.	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In ectothermic fish, the duration of the action potential varies with body 
temperature within the thermal tolerance range from 6.2°C to 41.7°C (Lopez-Olmeda and 
Sanchez-Vazquez  2011;Vornanen 2016; Vornanen and Hassinen 2016). For example, at 
19°C the duration of the ventricular action potential in zebrafish is similar to the one in 
humans at 37°C. However, at 37°C the duration of the ventricular action potential in 
zebrafish only represents one fifth of the human action potential (Vornanen and Hassinen 
2016). Action potential recordings have also been reported in embryonic zebrafish 
through the use of a patch clamp technique (Jou et al. 2010), and voltage sensitive dyes 
(Panáková et al. 2010; Wythe et al. 2011). 
 
2.3.4. Ion currents contributing to the action potential 
 
2.3.4.1. Sodium currents 
 
As in mammals, the rapid upstroke of the zebrafish cardiac action potential (phase 
0) is generated by a fast sodium (Na+) current (INa), in the atrium and in the ventricle. The 
current flows through voltage-gated Na+ channels, as demonstrated by Nemtsas et al. 
(2010). Indeed, exposure of the heart to the specific Na+ channel blocker tetrodotoxin 
induced a significant reduction in upstroke velocity to 25% in the atrium and 19% in the 
ventricle (reduced dV/dtmax), as well as a reduction in APA.  On the other hand, the 
duration of the action potential was not affected by tetrodotoxin, suggesting that there is 
no sustained (non-inactivating) INa. A study using isolated ventricular cardiomyocytes 
indicated that the density of the Na+ current in zebrafish was approximately four times 
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smaller than in mammals (Brette et al. 2008). In zebrafish, two Na+ channel isoforms, 
coded by the genes scn5Laa and scn5Lab, were found in larval cardiac tissue (72 hpf) 
(Novak et al. 2006; Vornanen and Hassinen 2016). These genes are orthologous to the 
mammalian gene SCN5A, and are required for cardiac development (Chopra et al 2010). 
In the adult zebrafish, only scn5Lab has been identified (Chopra et al 2010; Vornanen and 
Hassinen 2016). 
 
2.3.4.2. Calcium currents 
 
Ca2+ currents are necessary for the plateau phase (phase 2) of the action potential 
and they participate in contraction by triggering the interaction between actin and myosin. 
Two types of Ca2+ currents (ICa) have been demonstrated in adult zebrafish atrial and 
ventricular cardiomyocytes: the T-type (ICaT) and the L-type (ICaL) currents (Vornanen 
and Hassinen 2016).  
 
The L-type Ca2+ channel blocker nifedipine causes shortening of the action 
potential duration, and the ICaL activator BayK8644 causes prolongation of the QT 
interval in a dose-dependant manner, indicating that ICaL is responsible for the plateau 
phase of the action potential (phase 2) (Nemtsas et al. 2010; Tsai et al. 2011). Patch-
clamp recordings demonstrated that ICaL was associated with a fast run-down or decrease 
during the first few minutes after membrane rupture (Nemtsas et al. 2010). This 
phenomenon may be explained by the small cell size, which can cause run-down due to 
loss of important intracellular factors during cell dialysis (Nemtsas et al. 2010). 
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Alternatively, it may be a characteristic property of zebrafish α1C-channel subunits caused 
by the C-terminal sequence, which is reported to play an important role in run-down 
(Kepplinger et al. 2000, Nemtsas et al. 2010). It was also demonstrated that in the 
zebrafish, ventricular contraction was abolished by mutation in the α1C-channel subunit 
(Vornanen and Hassinen 2016). This subunit, also named Cav1.2, is the dominant cardiac 
isoform in mammals among four subunits (α1S, α1C, α1D, α1F, or Cav1.1-4), suggesting that 
it is produced by orthologous genes in mammals and zebrafish (Vornanen and Hassinen 
2016). Transcripts of the α1D-channel subunit are also expressed in the hearts of adult 
zebrafish (Sidi et al. 2004; Vornanen and Hassinen 2016). Notably, there is a significantly 
larger density of ICaL in zebrafish ventricular cardiomyocytes than in human 
cardiomyocytes (Zhang et al. 2011; Vornanen and Hassinen 2016). 
 
The expression of T-type Ca2+ channels in atrial and ventricular cardiomyocytes in 
the adult zebrafish was demonstrated by Nemtsas et al. (2010). ICaT was identified using 
the following criteria: 1) the potential range of activation (usually a low-voltage range), 2) 
insensitivity to nifedipine, 3) high sensitivity to nickel (Ni2+), and 4) resistance to 
tetrodotoxin for discrimination from INa. This substantial expression of T-type Ca2+ 
channels in adult zebrafish is very different from many mammalian hearts, where T-type 
Ca2+ channels are only expressed in the fetal heart and pathologically in the adult 
(Nemtsas et al. 2010). Two cardiac subunits for T-type Ca2+ channels are known in 
mammals, α1G and α1H (respectively also named Cav3.1 and Cav3.2). In zebrafish, T-type 
Ca2+ channels most likely consist of the subunit α1G based on their sensitivity to Ni2+ 
(Nemtsas et al. 2010). However, immunofluorescence findings suggested the presence of 
α1H subunits (Alday et al. 2014). Some authors speculate that the presence of ICaT 
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indicates that zebrafish cardiomyocytes in adults have a more immature phenotype than 
adult mammalian cardiomyocytes (Nemtsas et al. 2010). 
 
2.3.4.3. Potassium currents 
 
• Delayed rectifier potassium currents  
In zebrafish cardiomyocytes, only the IKr current has been clearly demonstrated by 
using the IKr blocker E4031, which substantially prolonged APD. This result sugests that 
the zebrafish heart does display an ether-à-go-go related gene (Nemtsas et al. 2010, Alday 
et al. 2014, Vornanen and Hassinen 2016). IKr is the main repolarizing potassium (K+) 
current in the atrial and ventricular myocytes, and is active during phase 2 and phase 3 of 
the cardiac action potential. Some studies suggest that zebrafish possess an ortholog of 
the mammalian KCNH2 gene called zerg (also called HERG in humans) coding for the 
pore-forming subunit of the K+ channel (Langheinrich et al. 2003; Arnaout et al. 2007; 
Scholtz et al. 2009; Leong et al. 2010). When this orthologous gene was mutated, 
zebrafish embryos exhibited electrocardiographic changes similar to humans with long 
QT syndrome LQT2, including increased Q-T interval and atrioventricular block 
(Langheinrich et al. 2003). Vornanen and Hassinen (2016) suggested that as opposed to 
mammals, IKr was mostly produced by erg2 channels, which are encoded by the zebrafish 
ortholog to the mammalian KCNH6 gene, mainly expressed in the nervous tissue and not 
in the heart, instead of erg1 channels (KCNH2 gene) mainly expressed in the mammalian 
heart. 
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The presence of IKs in zebrafish cardiomyocytes is still controversial (Verkerk and 
Remme 2012; Vornanen and Hassinen 2016). Nemtsas et al. (2010) concluded that IKs 
had no significant role in repolarization in adult zebrafish cardiomyocytes, because the IKs 
blocker HMR 1556 had no effect on membrane outward currents during patch-clamp 
recordings on isolated cardiomyocytes. In contrast, Tsai et al. (2011) found that the IKs 
blocker chromanol 293B prolonged both QT interval and action potential duration in a 
dose-dependent manner in adult zebrafish cardiomyocytes, suggesting the presence of IKs. 
Transcripts orthologous to the mammalian KCNQ1 gene are also expressed in the 
zebrafish heart (Wu et al. 2014). In mammals, the KCNQ1 gene encodes for the α-subunit 
(Kv7.1), which is part of the K+ channel responsible for IKs (Vornanen and Hassinen 
2016). Moreover, IKs has been identified in another species of the zebrafish family 
(Cyprinidae), Carassius carassius (Hassinen et al. 2011). In this case, IKs was mainly 
produced by homotetramers of Kv7.1 channel without the MinK β-subunit as in 
mammals. In humans, it was demonstrated that IKs blockade significantly increases APD 
only when “repolarization reserve” is attenuated or with sympathetic activation (Jost et al. 
2005; Verkerk and Remme 2012). This phenomenon may explain the contrasting results 
of studies assessing the effect of IKs blockade on the zebrafish action potential. 
• Inward rectifier potassium current 
As in mammals, a robust background of the inwardly rectifying K+ current IK1 is 
present in the atrial and ventricular cardiomyocytes of the zebrafish (Hassinen et al. 2015; 
Vornanen and Hassinen 2016). This current is also blocked by barium (Ba2+) (Hassinen et 
al. 2015). IK1 mainly participates in the maintenance of the resting membrane potential 
(phase 4), but also plays a role in early depolarization and late repolarization (phase 3). 
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However, marked differences were seen in terms of the composition of the channel 
responsible for IK1 compared with mammals. The main channel isoform identified in the 
zebrafish ventricle is Kir2.4, which represents 92.9 % of the total Kir2 population. In the 
zebrafish atrium, Kir2.2a and Kir2.4 represent 64.7 % and 29.3 % of the Kir2 transcripts, 
respectively (Hassinen et al. 2015; Vornanen and Hassinen 2016). In humans, by contrast, 
Kir2.4 is hardly expressed in cardiomyocytes and Kir2.1, Kir2.2 and Kir2.3 are 
predominant. These findings may have functional implications, as the zebrafish Kir2.4, 
for example, is approximately two times more sensitive to Ba2+ than its mammalian 
counterpart (Vornanen and Hassinen 2016). 
 
2.3.4.4. Other ionic currents 
 
• IK,ATP: The ATP-sensitive channels Kir6.1, Kir6.2 and Kir6.3 are present in the 
zebrafish genome, occupying three different chromosomes. Kir6.1 and Kir6.2 are 
orthologs to Kir6.1 and Kir6.2 of mammals (Zhang et al. 2006; Vornanen and 
Hassinen 2016). While Zhang et al (2006) presented Kir6.3 as a new member of 
the inward rectifier K+ channel family; others consider Kir6.3 as a paralog of 
Kir6.2 (i.e., Kir6.2b) (Vornanen and Hassinen 2016). 
• IK,ACh: Acetycholine (ACh) induces a large inwardly rectifying K+ current in the 
zebrafish heart (Nemtsas et al. 2010; Vornanen and Hassinen 2016). However, 
this effect is limited to the atrium and the molecular basis of this current has not 
been described at this time (Vornanen and Hassinen 2016). 
• Ih or If: The “pacemaker current” Ih has been identified in the zebrafish heart. The 
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slow mo mutation reduces Ih and heart rate in embryos and adult zebrafish (Baker 
et al. 1997; Warren et al. 2001). The transcription factor Isl1 is the first identified 
molecular marker for pacemaker cells in the zebrafish heart, and its expression in 
pacemaker cells is conserved from fish to human (Tessadori et al. 2012). Thanks 
to this marker, it was determined that the functional pacemaker of the zebrafish 
was likely organized as a ring around the venous pole (Figure 11) (Tessadori et al. 
2012). The presence of the hyperpolarization-activated cyclic nucleotide-gated ion 
channels HCN4, which are characteristic of mammalian pacemaker cells, was also 
detected in this region of the zebrafish heart (Tessadori et al. 2012; Stoyek et al. 
2015). 
 
 
Figure 11. Expression of Isl1 and likely location of the functional pacemaker in the 
adult zebrafish heart (Tessadori et al. 2012). A: Sagittal section through zebrafish heart labeled 
with the myocardial marker myl7. sv: sinus venosus; a: atrium; avc: atrioventricular canal; v: ventricle; ba: 
bulbus arteriosus.The box indicates the region of the sinoatrial junction. B: 3D reconstruction of the 
sinoatrial junction. Isl1 (yellow) is expressed around the entire sinoatrial junction, forming a ring-like 
structure.  
  
A	   B	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2.3.5. Excitation-contraction coupling 
 
As in all vertebrate hearts, cardiac contraction in zebrafish is caused by the 
generation of cross bridges between thick filaments composed of the protein myosin, and 
thin filaments mainly composed of the protein actin (Gillis 2011). The thin filaments of 
actin contain two chains that intertwine in a helical pattern, and each actin filament is 
carried on a twisting backbone of the heavier tropomyosin protein (Opie 2004). Each 
thick filament of myosin is composed of hundreds of myosin molecules that have a head 
and a tail. The tails are aligned side by side but the heads emerge in a spiral fashion. 
Within the cardiomyocytes, thick and thin filaments are arranged in a parallel overlapping 
patterns within structures called sarcomeres. Necessary to the interaction between actin 
and myosin are the cardiac troponin (cTn) complexes that occur at regular intervals along 
tropomyosin (Figure 12). Each cTn complex is composed of three types of proteins: the 
cardiac troponin C (cTnC, C for Ca2+) responds to the Ca2+ released as a result of the 
action potential during systole, and binds to the inhibitory molecule troponin I (cTnI, I for 
inhibitor) that otherwise restricts the interaction between actin and myosin heads. When 
Ca2+ is low, as in diastole, cTnI binds to actin to inhibit myosin interaction. Troponin T 
(cTnT, T for tropomyosin) is involved in distributing the inhibitory effect of the cTn 
complex, via tropomyosin, to other actin monomers with which it interacts in the absence 
of Ca2+. In the presence of Ca2+, cTnT removes these inhibitions. Thereby, Ca2+ handling 
has a key role in excitation-contraction coupling. 
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Figure 12. Schematic diagram of the cardiac sarcomere and of the regulatory 
complex associated with the actin filament responsible for making the contractile 
reaction activated by calcium (Gordon et al. 2001; Gillis 2011). TnC: troponin C; TnI: 
troponin I; TnT: troponin T. With permission of Elsevier. 
 
In mammals, the wave of depolarization leads to an influx of extracellular Ca2+ 
through the L-type calcium channels, which triggers the release of more Ca2+ from the 
sarcoplasmic reticulum by the process of Ca2+-induced Ca2+ release with activation of the 
ryanodine receptors (Opie 2004). This process requires a direct interface between the cell 
membrane and the sarcoplasmic reticulum membrane, which is made possible in 
mammalian cardiomyoctes by invaginations of the cell membrane called T-tubules. The 
cytosolic Ca2+ then increases and contraction occurs. During relaxation, cytosolic Ca2+ 
decreases thanks to the activity of the ATP-dependent Ca2+ uptake pump of the 
sarcoplasmic reticulum called SERCA, as well as trans-sarcolemmal calcium efflux 
through the Na+- Ca2+ exchanger (NCX) and a sarcolemmal Ca2+-ATPase.  
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As opposed to the situation in mammals, T-tubules are absent in zebrafish 
cardiomyocytes (Brette et al. 2008; Bovo et al. 2013; Haustein et al. 2015), and ryanodine 
receptors are not sensitive to the mechanism of Ca2+-induced Ca2+ release (Bovo et al. 
2013). As a result, trans-sarcolemmal Ca2+ influx has been suggested to be the main 
contributor to the increase in cytosolic Ca2+ (Ca2+ transient) during cardiac contraction 
while Ca2+-induced Ca2+ release from the sarcoplasmic reticulum appears to be less 
important (Figure 13) (Brette et al. 2008; Zhang et al. 2011; Bovo et al. 2013). The 
absence of T-tubules is compensated by the small diameter of fish cardiomyocytes and 
the presence of flask-like invaginations of the membrane (caveolae), both of which 
increase the cell surface-to-volume ratio (Galli 2011). This also would explain the larger 
density of ICaL in zebrafish ventricular cardiomyocytes compared with large mammals 
such as humans (Zhang et al. 2011; Vornanen and Hassinen 2016). However, a recent 
study in zebrafish suggests that sarcoplasmic Ca2+ release is more important than 
previously thought, especially in contractile force generation (Haustein et al. 2015). In 
contrast to mammals, it also was demonstrated that the force-frequency relationship is 
strongly negative in the zebrafish heart (Haustein et al. 2015). Mechanisms of relaxation 
have not been fully determined in zebrafish, but studies suggested that NCX significantly 
contributes to Ca2+ removal (Bovo et al. 2013; Haustein et al. 2015). This also was shown 
to be the primary pathway to remove cytosolic Ca2+ during relaxation in rainbow trout 
cardiomyocytes (Shiels 2011). 
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Figure 13. Calcium handling in the fish cardiomyocyte (Shiels 2011). The sarcolemma 
(SL) is being excited by an action potential (AP), which opens L-type Ca2+ channels (LTCC) in the cell 
membrane allowing Ca influx (red arrows) down its concentration gradient into the cell. Calcium can also 
enter the cell via reverse-mode Na+–Ca2+ exchange (NCX). Calcium influx can trigger calcium release from 
the sarcoplasmic reticulum (SR) through ryanodine receptors (RyR). Together, these calcium influxes cause 
a transient rise in calcium that initiates contraction at the myofilaments. Relaxation occurs when calcium is 
removed from the cytosol (green arrows) either back across the SL via forward-mode NCX or back into the 
SR via the SR Ca2+-pump (SERCA). With permission of Elsevier. 
 
As for cardiac action potentials, Ca2+ handling during excitation-contraction 
coupling depends on the environmental temperature (Shiels 2011; Vornanen 2016). The 
amplitude of the rising phase of the Ca2+ transient is correlated with the temperature: 
warm temperatures tend to increase the rate of rise of the Ca2+ transient and low 
temperatures tend to decrease the rate. This observation is partially caused by the L-type 
Ca2+ channels, which show increased kinetics at warm temperatures (Shiels 2011). 
Certain hormones can also play a role, such as epinephrine, which stimulates Ca2+ influx, 
and can counteract the effect of low temperatures when higher cardiac output is needed. 
In contrast to L-type Ca2+ channels, the activity of NCX is not significantly affected by 
the environmental temperature. However, the activity of SERCA is very temperature-
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dependent and its activity decreases markedly when temperature decreases (Shiels 2011). 
In this case as well, epinephrine can counteract this depression effect of cold temperatures 
by activating phospholamban, an accessory protein attached to SERCA (Shiels 2011). 
 
2.3.6.  Cardiovascular control: innervation of the zebrafish heart. 
 
As in mammals, cardiac output of zebrafish is regulated based on the body’s 
oxygen and metabolic demands and oxygen supply. The autonomic nervous system is the 
main controller of cardiac output by regulating heart rate and contractility, and is 
composed of the cranial limb or parasympathetic limb that causes cardioinhibition, and 
the spinal limb or sympathetic limb that causes cardioexcitation (Figure 14) (Nilsson 
2011; Zaccone et al. 2011; Stoyek et al. 2015). Each pathway is composed of two 
neurons, the preganglionic and postganglionic neurons.  
 
For the cranial autonomic limb, preganglionic neurons originate in vagal motor 
nuclei of the brainstem and project in the vagus nerve to synapse on postganglionic 
neurons in the intracardiac nervous system (Stoyek et al. 2015). Between the pre- and 
postganglionic neurons, the neurotransmitter ACh is released in the synaptic junction 
acting at postsynaptic nicotinic receptors. ACh also is released at the synaptic junction 
between postganglionic neurons and the myocardium, but it binds to muscarinic receptors 
(Stoyek et al. 2015).  
 
For the spinal autonomic limb, preganglionic neurons originate in spinal cord 
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nuclei and their axons leave the cord to synapse on somata of postganglionic neurons in 
the paravertebral ganglia. ACh is released at the preganglionic synaptic junctions acting 
on nicotinic receptors, and epinephrine or norepinephrine is released at the postganglionic 
synaptic junction acting on adrenergic receptors (Stoyek et al. 2015). Although the vagus 
is only parasympathetic at its origin, it receives postganglionic fibres from the 
sympathetic chain in the head region, creating the vagosympathetic trunk (Zaccone et al. 
2011). 
 
In teleost fish, chromaffin cells controlled by preganglionic neurons also cause 
cardioexcitation by releasing catecholamines into the bloodstream (Figure 14) (Nilsson 
2011). 
 
 
Figure 14. Autonomic cardiac control in teleost fish (Nilsson 2011). CATs: 
catecholamines; Symp: sympathetic; VS: vagosympathetic; X: vagus. With permission of Elsevier. 
 
The intracardiac nervous system in the zebrafish has been described in detail by 
Stoyek et al. (2015, in press). This work showed that all cardiac chambers were 
innervated using the pan-neuronal markers AcT and Hu (Figure 15). A major nerve 
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plexus called the sinoatrial plexus is located at the sinoatrial junction and receives inputs 
from the cardiac vagosympathetic rami. A few of these rami also project to the atrial wall 
and the atrioventricular junction. A second nerve plexus also is present at the 
atrioventricular junction surrounding the valve. The ventricle and bulbus arteriosus also 
are innervated by axons arising from the venous pole or entering the heart along the aorta. 
 
 
Figure 15. Organization of intracardiac nervous system demonstrated with 
acetylated tubulin (AcT) and human neuronal protein (Hu) immuhistochemistry 
(Stoyek et al. 2015). A,B: Whole mount of heart (A) and schematic (B) show an overview of the 
chambers of the heart and the major elements of cardiac innervation. Blood passes serially from the paired 
ducts of Cuvier (DC) into the sinus venosus (SV), through the sinoatrial valves and into the atrium (A), then 
into the ventricle (V), the bulbus arteriosus (BA), and the ventral aorta (VA) to the gills. The lower-boxed 
areas in A and B correspond to the region containing the sinoatrial valve, where the sinoatrial plexus (SAP) 
is located. The upper-boxed areas correspond to the region of the atrioventricular plexus (AVP) at the 
atrioventricular junction. RX, LX: right and left vagosympathetic trunks. With permission of John Wiley 
and Sons. 
 
Cholinergic innervation was demonstrated using immunoreactivity for choline 
acetyltransferase (ChaT), an enzyme involved in ACh synthesis, as well as an antibobody 
against vesicular acetylcholine transporter (VAChT) (Stoyek et al. 2015). The vast 
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majority of neurons in the sinoatrial region (sinoatrial plexus) showed uptake with ChaT 
and VAChT and thus were determined to be cholinergic. Muscarinic cholinergic type 2 
receptors (M2R) were also identified using immunohistochemical methods mainly in the 
sinoatrial and atrioventricular junctions where putative pacemaker cells were determined 
to be, as well as in the atrial and ventricular myocardium (Stoyek et al. in press). The 
density of M2R appeared to be significantly higher in the atrial myocardium than in the 
ventricular myocardium. All these regions also expressed adrenergic β2 receptors, but the 
density of this receptor was higher in the ventricular myocardium than in the atrial 
myocardium (Stoyek et al. in press). 
 
In summary, the zebrafish heart has been increasingly used as a model of 
mammalian, and especially human cardiac function. Zebrafish have similar properties to 
human hearts with respect to heart rate and action potential duration and morphology, 
although they differ with respect to the cardiac structure and ultrastructure and the 
molecular basis of the components of some cardiac ionic currents (Genge et al. 2016). On 
the whole, zebrafish are an attractive and useful model to study human electrophysiology. 
For the present study involving fish kills, they also appear to be a representative model 
for freshwater fish in general.  
 
To test the hypothesis that selected environmental toxicants lead to increased fish 
morbidity and mortality by precipitating cardiac rhythm disturbances, adult zebrafish 
hearts were exposed to selected toxicants in vitro in order to characterize their effects on 
action potential morphology.  
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3. Materials and methods 
 
3.1. Animals 
 
Wild-type zebrafish were obtained from two commercial suppliers (Aquatron 
Laboratory, Dalhousie University, Halifax, NS and Pet Culture, Charlottetown, PE). They 
were maintained in separate 20 L glass aquaria (40 x 20 x 25 cm) at a stocking density of 
maximum 1.5 fish/L. Temperature was maintained at approximately 27 °C by 
submersible heaters. The water was filtered through multistage external power filters with 
mechanical, chemical and biological components. Water aeration was provided using air 
stones. The light cycle was 10 hours on 14 hours off and fish were fed flake food daily 
(Nutrafin Max, Hagen, Montreal, QC). The mean ± standard deviation fish weight was 
1.09 g ± 0.41 (based on a sample of 20 fish from both providers). All fish were 
maintained and treated according to ethical guidelines of the CCAC; this project was 
approved by the University of Prince Edward Island Animal Care Committee (Protocol 
number: 13-020; File number: 6005334).  
 
3.2. Procedures common to all experiments 
 
• Fish euthanasia and heart explantation 
Zebrafish were euthanized using a two-step procedure. They were first 
anesthetized using tricainemethanesulfonate (TMS; 100-150 mg/L of water bath, buffered 
with sodium bicarbonate using a 1:1 ratio) (Matthews and Varga 2012; Leary et al. 2013; 
Spears et al. 2014). Secondly, after cessation of opercular movements, their hearts 
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(including atrium, ventricle and bulbus arteriosus, Figure 16) were rapidly excised under 
stereomicroscopy following a midline sternotomy and were immediately transferred to a 
plexiglas chamber, where they were immobilized to the floor of the chamber using a 
bipolar stimulating electrode and superfused with Tyrode’s solution (containing no TMS) 
at room temperature (approximately 20 °C) at a rate of approximately 30 ml/hour. All 
hearts were allowed to equilibrate for at least 15 min before intracellular action potentials 
were recorded (Nemtsas et al. 2010). Tyrode’s solution was of the following composition 
(in mM): NaCl 124, KCl 4, CaCl2 0.5, MgCl2 0.7, NaHCO3 24, NaHPO4 0.9, and D-
glucose 5.5. CaCl2 concentration was reduced in order to decrease contractility and obtain 
more stable recordings. Although a stimulating electrode was used to immobilize the 
heart, no stimulation was used for the purpose of the present study. 
 
 
Figure 16. Adult zebrafish heart after explantation from the throracic cavity. The 
heart measures approximately 1 mm in diameter. A: atrium; V: ventricle; BA: bulbus arteriosus. 
 
• Action potential recordings 
The setup is shown in Figure 17. Transmembrane action potentials were recorded 
with sharp machine-pulled glass capillary electrodes (1 mm diameter borosilicate 
V	  
A	  BA	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capillaries, World Precision Instruments, Saratosa, FL) filled with 3M KCl connected to 
an amplifier (Duo 773,World Precision Instruments, Saratosa, FL) via a Ag/AgCl wire 
and a probe (712P, World Precision Instruments, Saratosa, FL). The reference electrode 
(Ag/AgCl pellet, World Precision Instruments, Saratosa, FL) was immersed in the bath 
and connected to the amplifier. The amplifier was connected to an oscilloscope (2522A, 
BK Precision, Yorba Linda, CA) and to a personal computer. Each heart was visualized 
using a fixed stage upright microscope (Olympus BX51WP, Richmond Hill, ON) placed 
on a vibration isolation table (Technical Manufacturing Corporation, Peabody MA) in a 
custom-made Faraday cage, and recordings were obtained from the epicardial surface of 
the heart. The microelectrode was positioned using a hydraulic micromanipulator 
(MP285, Sutter Instrument Company, Novato, CA). Action potentials from stable 
impalements were recorded with a sampling rate of 1 or 10 kHz using a custom written 
data acquisition program (Real Time Experiment Interface RTXI, rtxi.org) and off-line 
analysis was performed using custom-written programs written in MATLAB 
(MathWorks, Natick, MA). Measured parameters included APD 90, APD 50 and APA. 
For each recording, parameters were measured from 10 consecutive action potentials and 
were averaged. The solutions used for superfusion were contained in 60 mL syringes and 
switched manually using three-way stopcocks. All treatments were diluted in Tyrode’s 
solution (same formula as above). When solutions were switched (from plain Tyrode’s 
solution to a treatment), action potential parameters were measured only once a stable 
morphology could be visualized on the oscilloscope (typically 15-30 min after switching). 
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Figure 17. Intracellular action potential recording setup. 1: vibration isolation table; 2: 
supertable with Faraday cage; 3: microscope; 4: hydraulic micromanipulator; 5: controller unit for hydraulic 
micromanipulator; 6: superfusion system; 7: waste; 8: amplifier; 9: oscilloscope; 10: personal computer. 
 
3.3. Treatments 
 
All treatments performed are summarized in Table 4. The compounds that were 
tested are summarized in Table 5. 
 
 
 
 
 
1	  
2	  
3	  
4	  
5	  
6	  
7	  
8	  
9	  
10	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3.3.1. Choice of toxicants to investigate 
 
The choice of toxicants to investigate was based on the list of agricultural 
pesticides commonly used in PEI, as well as past fish kills in PEI for which specific 
pesticides have been identified in run-offs and may have contributed to fish mortality: 
• Chlorothalonil (2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile)  
Chlorothalonil is a broad-spectrum organochlorine fungicide and mildewicide 
extensively used on PEI’s potato crops (Van Scoy and Tjeerdema 2014; DCLE 2015c). It 
has been suspected of contributing to several fish kills in PEI over the past 20 years 
(Mutch 2002; MacPhail 2013). The effect of chlorothalonil on the ventricular action 
potential morphology was qualitatively assessed using a concentration found in PEI run-
off (3.8 nM or 0.2 µg/ml) and with a high concentration (94.0 nM or 5 µg/ml) (Purcell 
and Giberson 2007). No visible change of action potential morphology was identified 
with a low concentration and the effect seen with a high concentration (mainly shortening 
of APD) was similarly seen when hearts were exposed to chlorothalonil’s vehicle, 
acetonitrile, exclusively. Based on these preliminary observations, further experiments 
with this pesticide were not pursued.  
 
• Acetylcholinesterase inhibitors (AChEIs)  
AChEIs such as organophosphates or carbamates are very commonly used as 
pesticides in agriculture and cause toxic effects due to the accumulation of the 
neurotransmitter ACh at parasympathic neuroeffector junctions (Roberts and Reigarts 
2013). Organophosphates primarily act by phosphorylation of the acetylcholinesterase 
enzyme (AChE), while carbamates act by carbamylation of AChE (Roberts and Reigarts 
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2013). The decision to investigate the effect of AChEIs on zebrafish action potential 
morphology was motivated by the extensive use of this class of pesticide in PEI (DCLE 
2015c). Indeed, mancozeb, a dithiocarbamate fungicide, represents the leading pesticide 
sold in PEI in kilograms per year and was suspected to contribute to several fish kills in 
PEI (MacPhail 2013; DCLE 2015c). Phorate is the most commonly sold organophosphate 
(in kilograms per year) in PEI (DCLE 2015c). Moreover, a study from Abramochkin et 
al. (2008) revealed that exposure of cod atria to high concentrations of ACh caused 
suppression of electrical activity, an effect called the “cholinergic non-excitability 
phenomenon”. Preliminary qualitative experiments revealed a visible effect on atrial 
action potential morphology of ACh at a high concentration (10 µM) and further 
experiments evaluating the effects of ACh, a documented AChEI, physostigmine, and the 
commonly used pesticides mancozeb and phorate were pursued. Action potential 
recordings were performed on the atrium, because cholinergic innervation appears more 
prominent in the atrium than in the ventricle (Newton 2010; Stoyek et al. 2015). 
 
3.3.2. Treatments with acetylcholine (treatments 1a, 1b and 1c) 
 
Because the effect of ACh on the atrial action potential morphology had not been 
previously investigated in zebrafish, initial experiments consisted of evaluating the effects 
of a low concentration of ACh (1 µM, n = 5, treatment 1a) as well as a high concentration 
of ACh (10 µM, n = 6, treatment 1b) on APD 90, APD 50 and APA. The same 
impalements were maintained throughout these experiments.  
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The reversible effect of ACh was assessed after exposure to a high concentration 
of ACh (treatment 1b) while maintaining the same atrial impalements. After recordings 
were obtained following exposure to ACh 10 µM, all preparations were superfused with 
Tyrode’s solution until the action potential morphology had stabilized (approximately 15-
30 min). APD 90, APD 50 and APA, were again measured after ACh was washed-out. 
 
In order to assess whether ACh was acting via muscarinic receptors, another set of 
experiments was performed (n = 5). Each heart was exposed to a high concentration of 
ACh (10 µM), followed by atropine (1 µM, antagonist of the muscarinic receptors) + ACh 
(10 µM) (treatment 1c). Because the same impalement could not be maintained during all 
experiments of this set, only APD 90 was measured at baseline (Tyrode’s solution), after 
exposure to ACh (10 µM), and after exposure to atropine (1 µM) + ACh (10 µM). 
 
3.3.3. Treatment with physostigmine (treatment 2) 
 
The effect of a documented AChEI, physostigmine (50 µM), was assessed on 
APD 90, APD 50 and APA in the presence of a low concentration of ACh (1 µM) (n = 6). 
The same atrial impalements were maintained throughout these experiments. It has been 
previously documented that physostigmine at a concentration of 50 µM significantly 
reduces AChE activity in zebrafish embryos (Küster 2005). 
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3.3.4. Treatment with mancozeb (treatment 3) 
 
The effect of the pesticide mancozeb (18.5 µM or 10 mg/L) was assessed on APD 
90, APD 50 and APA in the presence of a low concentration of ACh (1 µM) (n = 6). The 
same atrial impalements were maintained throughout these experiments.  
 
3.3.5. Treatment with phorate (treatment 4) 
 
The effect of the pesticide phorate (38.4 µM or10 mg/L) was assessed on APD 90, 
APD 50 and APA in the presence of a low concentration of ACh (1 µM) (n = 6). The 
same atrial impalements were maintained throughout these experiments.  
 
Table 4: Summary of the different treatment protocols. 
Treatment 
group 
Treatment performed Number of 
experiments (n) 
1a ACh 1 µM 5 
1b ACh 10 µM, followed by washing with Tyrode’s solution 6 
1c ACh 10 µM, followed by atropine 1 µM + ACh 10 µM 4 
2 Physostigmine 50 µM + ACh 1 µM 5 
3 Mancozeb 18.5 µM (10 mg/L) + ACh 1 µM 6 
4 Phorate 38.4 µM (10 mg/L) + ACh 1 µM 6 
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Table 5: Mechanisms of action, chemical properties, and structures of the tested 
compounds (INERIS 2017; NCBI 2017). 
 
Molecule 
Mechanism of action 
and chemical 
properties 
Structure 
Acetylcholine  
chloride 
- Cholinergic receptor 
agonist  
- MW: 181.7 g/mol 
- Solubility in water: 100 
mg/mL 
 
 Cl- 
Physostigmine 
hemisulfate 
- Cholinesterase inhibitor 
(carbamate) 
- MW: 324.4 g/mol 
- Solubility in water: 32 
g/L 
 
 1/2H2SO4 
Mancozeb - Cholinesterase inhibitor 
(carbamate) 
- MW: 541.1 g/mol 
- Solubility in water: 2-20 
mg/L 
 
 
Phorate - Cholinesterase inhibitor  
(organophosphate) 
- MW: 260.4 g/mol 
- Solubility in water: 50 
mg/L 
 
 
 
3.4. Statistical Analysis 
 
All statistical analysis was performed using Prism 7 for Mac OS X (GraphPad 
Software, La Jolla, CA). Each treatment was considered to be an independent set of 
independent experiments (one fish per experiment). For treatments 1a, 3 and 4, 
differences between baseline values and post-treatment values for each parameter (APD 
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90, APD 50 and APA) were assumed to be normally distributed based on Shapiro-Wilk 
normality tests and graphical examination of residuals, and were compared using paired t-
tests. Statistical significance was defined as P < 0.05. In order to address potential Type I 
error, it was mentioned whether or not statistically significant results would withstand 
Bonferroni’s correction. Bonferroni’s correction was applied to paired t-test results by 
dividing the alpha of 0.05 by 3, the number of variables tested within each treatment 
(APD 90, APD 50 and APA) to obtain a lower P-value of 0.0167. 
 
Non-parametric Friedman tests were used for treatments 1b and 1c (In these cases 
assumptions for repeated measures ANOVA could not be met). Multiple comparisons 
were performed using Dunn’s tests. 
 
Because the experiments of treatment 1b were chronologically performed first, a 
power analysis based on the results of this treatment revealed that at least 4 experiments 
were necessary to detect a significant change (P < 0.05) in APD 90 with a power of 80% 
(G*Power, version 3.1.9.2, Heinrich Heine Universität, Düsseldorf). Based on these 
results, at least 4 experiments (4 different fish) were used for other treatments (1a, 2, 3 
and 4).  
 
For each parameter (APD 90, APD 50 and APA), treatments 1b, 3 and 4 were 
compared with treatment 1a using a one-way analysis of variance (ANOVA) with 
Dunnett’s adjustments for multiple comparisons. Homogeneity of variance was first 
calculated as the ratio between largest and smallest group standard deviation, which 
should not exceed 2. Normal distribution of residuals was determined graphically.  
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4. Results 
 
4.1. Treatments with acetylcholine (treatments 1a, 1b and 1c) 
 
• Treatment 1a 
A low concentration of ACh (1 µM) caused a significant reduction in APD 90 and 
in APD 50, but no significant reduction in APA in atrial myocytes (Table 6, Figure 18). 
These results did withstand Bonferroni’s correction.  
 
• Treatment 1b 
A high concentration of ACh (10 µM) caused a significant reduction in APD 90, 
in APD 50, and in APA in atrial myocytes (Table 7, Figure 19). The effect of ACh 
persisted during the immediate washing period for three out of five experiments, while it 
appeared reversible in two experiments. No significant difference could be identified 
between exposure to ACh and washing with Tyrode’s solution for any of the action 
potential parameters. 
  
• Treatment 1c 
The effect of ACh (10 µM) on APD 90 was reversed with atropine, suggesting an 
effect of ACh on muscarinic receptors (Table 8, Figure 20).  
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Table 6. Atrial action potential parameters before and after exposure to acetylcholine (1 µM) – treatment 1a (n = 5). 
 Baseline ACh 1 µM P-value 
APD 90 (ms) 142.5 ± 11.2 (128.1-157.9) 106.2 ± 17.5 (88.1-134.3) 0.0107*† 
APD 50 (ms) 117.5 ± 8.9 (109.6-131.8) 78.4 ± 19.8 (61.3-112.1) 0.0099*† 
APA (mV) 104.3 ± 4.4 (98.5-109.6) 95.9 ± 5.5 (90.9-105.3) 0.0531 
ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; APA: action potential 
amplitude. Baseline heart rate: 100 ± 39 bpm (66-164). Results expressed as mean ± standard deviation (range);  *: P < 0.05; †: P < 0.0167 (after Bonferroni’s 
correction). t-values (degrees of freedom) for APD 90, APD 50 and APA: 4.52 (4),  4.61 (4), 2.71 (4), respectively. 
 
 
Figure 18. Atrial action potential parameters before and after exposure to acetylcholine (1 µM) – treatment 1a (n = 5). ACh: 
acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; APA: action potential amplitude; 
*: P < 0.05. 
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Table 7. Atrial action potential parameters before and after exposure to acetylcholine (10 µM) followed by a washing period – 
treatment 1b (n = 6). 
 
Baseline ACh 10 µM Washing 
Adjusted  
P-value 
Baseline vs ACh 
Adjusted  
P-value 
ACh vs Washing 
Adjusted 
 P-value 
Baseline vs Washing 
APD 90 (ms) 114.7 ± 35.5  
(69.9-176.0) 
59.2 ± 41.3  
(29.4-133.6) 
75.6 ± 54.6 
(32.6-157.6) 
0.0045* 0.1299 0.7446 
APD 50 (ms) 86.2 ± 21.5  
(50.4-109.6) 
29.7 ± 23.1  
(12.6-71.3) 
46.3 ± 43.9 
(13.1-109.3) 
0.0117* 0.4467 0.4467 
APA (mV) 93.6 ± 10.4  
(81.7-104.1) 
71.8 ± 21.6  
(46.6-96.8) 
88.4 ± 12.4 
(72.6-102.2) 
0.0117* 0.0628 >0.9999 
ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; APA: action potential 
amplitude. Baseline heart rate: 111 ± 19 bpm (74-125). Results expressed as mean ± standard deviation (range); vs: versus; *: P < 0.05. Friedman statistics for 
APD 90, APD 50 and APA: 10.33, 8.33, 9.33, respectively. 
 
 
Figure 19. Atrial action potential parameters before and after exposure to acetylcholine (10 µM) followed by a washing period 
– treatment 1b (n = 6). ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% 
repolarization; APA: action potential amplitude; *: P < 0.05.  
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Table 8. Atrial action potential parameters before and after exposure to acetylcholine (10 µM) followed by atropine (1 µM) – 
treatment 1c (n = 4). 
 
Baseline ACh 10 µM Atropine 1 µM + ACh 10 µM 
Adjusted  
P-value 
Baseline vs ACh 
Adjusted  
P-value 
Atropine + ACh 
vs ACh 
Adjusted  
P-value 
Baseline  
vs Atropine + ACh 
APD 90 (ms) 118.8 ± 24.6  (83.3-138.0) 
75.83 ± 37.54  
(31.8-121.3) 
155.3 ± 26.84  
(129.6-191.6) 
0.4719 0.0140* 0.4719 
ACh: acetylcholine; APD 90: action potential duration at 90% repolarization. Baseline heart rate: 109 ± 49 bpm (66-176). Results expressed as mean ± standard 
deviation (range); vs: versus; *: P < 0.05. Friedman statistic for APD 90: 8. 
 
 
Figure 20. Atrial action potential parameters before and after exposure to acetylcholine (10 µM) followed by atropine (1 µM) – 
treatment 1c (n = 4). ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; *: P < 0.05. 
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4.2. Treatment with physostigmine (treatment 2) 
 
Physostigmine (50 µM), in presence of a low concentration of ACh (1 µM), 
caused near-complete suppression of electrical activity in atrial myocytes in all 
experiments (Figures 21 and 22). The very short and narrow atrial action potentials were 
not detectable by the program used for analysis. Baseline values are presented in Table 9. 
 	  
 
Figure 21. Suppression of atrial action potential induced by physostigmine (50 µM) 
in presence of a low concentration of acetylcholine (1 µM). A: Experiment 1 of treatment 2 
(action potential parameters at baseline: APD 90: 133.1 ms, APD 50: 99.2 ms, APA: 85.8 ms); B: 
Experiment 3 of treatment 2 (action potential parameters at baseline: APD 90: 101.8 ms, APD 50: 80.9 ms, 
APA: 101.1 ms). 
 
 
Figure 22. Change in action potential morphology induced by physostigmine (50 
µM) in presence of a low concentration of acetylcholine (1 µM). A: Atrial action potential 
at baseline; B: Atrial action potential after exposure to physostigmine (50 µM) +ACh (1 µM). These 
recordings are magnified images of the experiment shown in figure 21A. Action potential parameters at 
baseline: APD 90: 133.1 ms, APD 50: 99.2 ms, APA: 85.8 ms. 
A B 
A B 
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Table 9. Atrial action potential parameters at baseline – treatment 2 (n = 5). 
 Baseline 
APD 90 (ms) 121.1 ± 24.7 (91.5-153.1) 
APD 50 (ms) 92.7 ± 22.2 (66.9-126.2) 
APA (mV) 89.1 ± 12.4 (76.5-103.1) 
APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% 
repolarization; APA: action potential amplitude. Baseline heart rate: 103 ± 30 bpm (83-153). Results 
expressed as mean ± standard deviation (range). 
 
4.3. Treatment with mancozeb (treatment 3) 
 
Mancozeb (18.5 µM), in presence of a low concentration of ACh (1 µM), caused a 
significant reduction in APD 90 and in APD 50 in atrial myocytes (Table 10, Figure 23). 
This reduction was modest and statistical significance did not withstand Bonferroni’s 
correction. No significant change in APA was observed. 
 
4.4. Treatment with phorate (treatment 4) 
 
Phorate (38.4 µM), in presence of a low concentration of ACh (1 µM), caused a 
significant reduction in APD 90, in APD 50, and in APA in atrial myocytes (Table 11, 
Figure 24). The reductions in APD 90 and APD 50 did withstand Bonferroni’s correction. 
The reduction in APA was modest and statistical significance did not withstand 
Bonferroni’s correction for this parameter. 
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Table 10. Atrial action potential parameters before and after exposure to mancozeb (18.5 µM ) + acetylcholine (1 µM) – 
treatment 3 (n = 6). 
 Baseline Mancozeb 18.5 µM   + ACh 1 µM P-value 
APD 90 (ms) 129.2 ± 20.4 (91.69-144.6) 99.8 ± 30.7 (63.0-137.9) 0.0493* 
APD 50 (ms) 105.3 ± 17.4 (72.9-121.4) 75.7 ± 33.7 (34.0-116.5) 0.0374* 
APA (mV) 96.3 ± 8.4 (88.4-107.3) 100.0 ± 8.8 (86.4-109.9) 0.4275 
ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; APA: action potential 
amplitude. Baseline heart rate: 78 ± 23 bpm (45-99). Results expressed as mean ± standard deviation (range);  *: P < 0.05; †: P < 0.0167 (after Bonferroni’s 
correction). t-values (degrees of freedom) for APD 90, APD 50 and APA: 2.58 (5),  2.81 (5), 0.86 (5), respectively. 
 
Figure 23. Atrial action potential parameters before and after exposure to mancozeb (18.5 µM ) + acetylcholine (1 µM) – 
treatment 3 (n = 6). ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; 
APA: action potential amplitude; *: P < 0.05 
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Table 11. Atrial action potential parameters before and after exposure to phorate (38.4 µM ) + acetylcholine (1 µM) – 
treatment 4 (n = 6). 
 Baseline Phorate 38.4 µM   + ACh 1 µM P-value 
APD 90 (ms) 122.5 ± 5.7 (114.8-129.2) 75.8 ± 15.5 (57.1-96.6) 0.0010*† 
APD 50 (ms) 99.6 ± 4.8 (93.2-106.8) 44.8 ± 16.4 (23.6-67.4) 0.0004*† 
APA (mV) 94.6 ± 4.5 (88.0-98.8) 84.5 ± 10.6 (71.5-96.4) 0.0454* 
ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; APA: action potential 
amplitude. Baseline heart rate: 94 ± 30 bpm (47-130). Results expressed as mean ± standard deviation (range);  *: P < 0.05; †: P < 0.0167 (after Bonferroni’s 
correction). t-values (degrees of freedom) for APD 90, APD 50 and APA: 6.91 (5), 8.31 (5), 2.65 (5), respectively. 
 
 
Figure 24. Atrial action potential parameters before and after exposure to phorate (38.4 µM ) + acetylcholine (1 µM) – 
treatment 4 (n = 6). ACh: acetylcholine; APD 90: action potential duration at 90% repolarization; APD 50: action potential duration at 50% repolarization; 
APA: action potential amplitude; *: P < 0.05. 
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4.5. Between-group comparisons of atrial action potential parameters 
 
The relative effects of treatments 1b, 3 and 4 were compared to the relative effect 
of treatment 1a on APD 90, APD 50 and APA. Physostigmine caused a dramatic effect 
on APD 90, APD 50 and APD with almost complete loss of electrical activity, and could 
not be included in the subsequent analysis. 
 
• APD 90 
All treatments caused a significant reduction in APD 90 (Figure 25). There was 
no significant effect of treatment on the relative change from baseline in APD 90 using a 
one-way ANOVA: F(3,19) = 1.64, P = 0.21. 
 
 
Figure 25. Relative change from baseline in action potential duration at 90% 
repolarization (APD 90). *: indicates significant change from baseline, P < 0.05. 
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• APD 50 
All treatments caused a significant reduction in APD 50 (Figure 26). There was 
no significant effect of treatment on the relative change from baseline in APD 50 using a 
one-way ANOVA: F(3,19) = 2.34, P = 0.11. 
 
Figure 26. Relative change from baseline in action potential duration at 50% 
repolarization (APD 50). *: indicates significant change from baseline, P < 0.05. 
 
• APA 
Only treatments 1b (ACh 10 µM) and 4 (phorate 38.4 µM + ACh 10 µM) caused 
a significant decrease in APA (Figure 27). There was a significant effect of treatment on 
the relative change from baseline in APA using a one-way ANOVA: F(3,19) = 6.37, P = 
0.003. However, there was no significant difference between the relative effects of 
treatment 1a (1 µM) and the relative effects of treatments 1b, 3 and 4 (1a-1b: P = 0.10; 
1a-3: P = 0.15; 1a-4: P = 0.99). 
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Figure 27. Relative change from baseline in action potential amplitude (APA). *: 
indicates significant change from baseline, P < 0.05. 
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5. Discussion 
 
5.1. Overview of objectives 
 
 The primary goal of the present study was to test the hypothesis that selected 
environment toxicants lead to increased fish morbidity and mortality by depressing 
cardiac function, and more specifically by precipitating cardiac rhythm disturbances. To 
test this hypothesis, adult zebrafish hearts were used as models and exposed to selected 
toxicants in vitro in order to characterize their effects on action potential morphology.  
 
 Based on historical data on fish kills in PEI, pesticide sales statistics, and 
preliminary experiments, my work focused on evaluating the effects of cholinesterase-
inhibiting pesticides, including the two main classes: organophosphates and carbamates. 
Due to the prominent cholinergic innervation of the zebrafish atrial myocardium, I used 
standard microelectrode techniques to record atrial action potentials exclusively. The 
effect of ACh on the atrial action potential morphology was described first. Although 
previous studies determined the effect of ACh on atrial action potential morphology in 
other fish species, this effect had not been previously evaluated in zebrafish and it is 
known that atrial cholinergic innervation varies among teleost species (Newton et al. 
2013). Following these experiments, zebrafish hearts were exposed to AChEIs, 
including the documented AChEI physostigmine and pesticides commonly used in PEI: 
mancozeb and phorate. The results of my study are discussed below. 
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5.2. Effects of acetylcholine (treatments 1a, 1b and 1c)  
 
In these experiments, I revealed the depressive effects of ACh on the atrial action 
potential in zebrafish. Indeed, exposure to low concentrations of ACh caused a 
significant reduction in atrial action potential duration (APD 90 and APD 50) and 
exposure to high concentrations of ACh also caused a significant reduction in APA. This 
phenomenon has been named cholinergic non-excitability and has been previously 
observed in the atrial myocardium of other teleosts including cod (Gadus morhua), carp 
(Cyprinus carpio), and trout (Oncorhynchus mykiss), as well as in frogs (Rana 
temporaria and Rana cotesbeiana) (Rozenshtraukh and Kholopov 1975; Giles and 
Noble 1976; Molina et al. 2007; Abramochkin et al. 2008; Abramochkin et al. 2009; 
Abramochkin et al. 2010). Cholinergic non-excitability appears to affect lower 
vertebrates only, because ACh has not been reported to alter APA in mammals or 
reptiles (Abramochkin et al. 2010). In dogs, for example, ACh only induces 
hyperpolarization of the resting membrane potential and shortening of APD (Calloe et 
al. 2013). It is worth mentioning that the graphs representing APD 90 and APD 50 
followed the same pattern, suggesting that when APD 90 dramatically decreases APD 50 
also dramatically decreases, and inversely. 
 
The changes observed in atrial action potential morphology can lead to several 
deleterious consequences, including:  
 
1) Reduced contractility caused by APD shortening, which in turn diminishes 
calcium influx during the plateau phase of the action potential (Ten Eick et al. 1976). 
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Although inotropy appeared subjectively depressed during experiments with ACh, the 
present study was not designed to quantitatively measure contractility.  
2) Bradycardia or asystole. If a large proportion of the atrium becomes 
inexcitable, electrical conduction to the atrioventricular junction and ventricle may be 
interrupted and ventricular contraction may only rely on subsidiary ventricular 
pacemaker activity (escape rhythm). The heart rate generated by an escape focus is by 
definition slower than the sinus rate. Moreover, it has been demonstrated that ACh also 
reduces or even supresses the depolarization rate of cardiac pacemaker cells in fish, 
which can lead to asystole (Saito 1973). Optical mapping experiments revealed full 
cessation of electrical activity in approximately 60% of studied atrial zones after 
exposure to ACh (10 µM) in carp and frog (Abramochkin et al. 2010).  
 
3) Initiation of reentry circuits and tachyarrhythmias. The effect of ACh is not 
uniform through the atrial myocardium, and this heterogeneity creates an 
arrhythmogenic substrate by facilitating the initiation and maintenance of reentry 
circuits (Abramochkin et al. 2010, Dobrev et al. 2014). Reentry is defined as continuous 
impulse propagation around a functional barrier (such as inexcitable areas of the atrial 
myocardium caused by ACh) or an anatomical obstacle. Moreover, one requirement for 
the maintenance of reentry is that the initially activated tissue regains excitability while 
the electrical impulse propagates around the reentry circuit. Recovery of excitability is 
more likely when the effective refractory period becomes shorter, as seen with a reduced 
APD duration (Dobrev et al. 2014). Lin et al. (2007) demonstrated the initiation of atrial 
tachyarrhythmias caused by ACh (1-10 µM) in tilapia fish. This mechanism has also 
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been demonstrated to initiate vagally induced atrial fibrillation in mammals and frogs 
(Dobrev et al. 2014; Abramochkin et al. 2010). 
 
In mammals, ACh is known to alter action potential morphology via modulation 
of several ionic currents, including activation of the inwardly rectifying current IK,ACh, 
suppression of ICaL, and in pacemaker cell suppression of If (Ten Eick et al. 1976; 
Renaudon et al. 1997; Harvey and Belevych 2003; Dobrev et al. 2014). ACh modulates 
these currents via the activation of the muscarinic cholinoreceptors M2R (Dobrev et al. 
2014). Binding of ACh to M2R leads to dissociation of Gi proteins and direct activation 
of the IK,ACh channels by Gβγ-subunits. The exact ionic mechanisms by which ACh alters 
atrial action potential morphology in fish are not fully understood yet, but several studies 
have suggested the presence of a strong inwardly rectifying current mediated by ACh in 
atrial myocardium (Molina et al. 2007, Nemtsas et al. 2010). Abramochkin et al. (2010) 
demonstrated that barium chloride (BaCl2) completely prevented the onset of cholinergic 
non-excitability, including suppression of APA. Ba2+ is known to block channels 
responsible for IK,ACh and for the background inwardly rectifying current IK1 (Hassinen 
et al. 2008). Because ACh has not been shown to affect IK1 in fish, it is suspected that 
the suppression of APA is related to IK,ACh alterations (Harvey and Belevych 2003; 
Abramochkin et al. 2010). Furthermore, recent experiments in crucian carp (Carassius 
carassisus) and rainbow trout (Oncorhynchus mykiss) revealed the likely existence of a 
new cardiac inward rectifier current modulated by ACh, named IK,ACh2. As opposed to 
IK,ACh and IK1, IK,ACh2 is mostly an outward current with only a small inward component 
(Abramochkin et al. 2014). IK,ACh2 also was shown to be activated by M2R stimulation. 
This newly discovered current might contribute to the decrease in APA observed in 
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some fish and amphibians. In the present study, the cholinergic non-excitability 
phenomenon on atrial myocardium was demonstrated for the first time in zebrafish. The 
effect of ACh was reversed by atropine, suggesting activation of M2R receptors. Based 
on the recent findings from Abramochkin et al. (2014), I speculate that IK,ACh2 may be 
present in zebrafish as well. 
 
5.3. Effects of physostigmine (treatment 2) 
 
A large proportion of pesticides currently in use are AChEIs, including 
organophosphates and carbamates. Organophosphorus pesticides were first developed in 
Germany in the 1930s and were initially used as chemical weapons (nerve agents) 
(Fulton and Key 2001; King and Aaron 2015). They are potent insecticides and have 
become attractive because of their rapid degradation in the environment. They are now 
the most widely used classes of insecticides worldwide (Fulton and Key 2001; King and 
Aaron 2015). AChEIs act by inhibiting synaptic AChE, which normally prevents further 
downstream neurotransmission by hydrolyzing ACh to acetate and choline. The 
inactivation of AChE by the binding of organophosphates or carbamates leads to 
accumulation of ACh at the synapses of all autonomic ganglia, at many autonomically 
inervated organs, including the heart, at the neuromuscular junction, and at many 
synapses in the central nervous system (King and Aaron 2015).  
 
Organophosphates and carbamates inhibit AChE by causing phosphorylation or 
carbamylation of the AChE protein catalytic site (King and Aaron 2015). However, 
carbamate-AChE bonds spontaneously hydrolyze more rapidly and their effects are 
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more readily reversible. Although AChEIs are rapidly degraded in the environment, they 
generally lack target specificity and can be acutely toxic to many nontarget vertebrate 
and invertebrate species (Fulton and Key 2001). In fish, AChEI pesticides have been 
shown to cause cardiac developmental abnormalities, as well as rhythm disturbances, 
including bradycardia and tachyarrhythmias (Lin et al. 2007; Jee et al. 2009; Tryfonos et 
al. 2009; Simoneschi et al. 2014; Watson et al. 2014; Du et al. 2015; Pamanji et al. 
2015). Considering the effects caused by high concentrations of ACh on the atrial action 
potential (i.e., cholinergic non-excitability) I speculated that AChEIs, which lead to ACh 
accumulation, would produce comparable changes that may cause acute cardiac 
depression and subsequent death. Prior to the present study, only one publication 
reported the effect of an AChEI, paraoxon (5-50 µM), on the atrial action potential 
morphology of fish (cod, Gadus morhua) (Abramochkin et al. 2012). Paraoxon caused 
significant reduction in APD but did not alter APA, as opposed to high concentrations of 
ACh.  
 
Before testing the effects of AChEIs commonly used in PEI, this series of 
experiments first involved investigating the effect of a known and documented AChEI, 
physostigmine also known as eserine. Physostigmine is the active ingredient of the 
ordeal bean of Old Calabar in Nigeria (Physostigma venenosum Balfour), which was 
used to determine if individuals were innocent or guilty of some serious misdemeanour 
in the mid-19th century. It also was the first carbamate isolated by Europeans (Fulton and 
Key 2001; Proudfoot 2006). The effect of physostigmine on the heart of fish has been 
documented since at least 1941, when physostigmine was shown to cause bradycardia in 
hearts of common carp (Cyprinus carpius) and tench (Tinca vulgaris) (Filippova 1941). 
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Jullien and Ripplinger (1949) demonstrated that intracoelomic injections of 
physostigmine in smoothhounds (Mustelus laevis, now called Mustelus mustelus, which 
is a type of shark) and blackscorpion fish (Scorpaena porcus, which is a teleost) caused 
a significant increase in acetylcholine concentration in cardiac tissues (as high as six-
fold). Physostigmine at a concentration of 50 µM significantly reduced AChE activity in 
zebrafish embryos (Küster 2005). However, the effect of physostigmine on the atrial 
action potential of fish had not been investigated prior to my study. My results showed a 
dramatic suppression of atrial action potentials in all experiments using physostigmine 
(50 µM) in the presence of a low concentration of ACh (1 µM) acting as a substrate. All 
action potential parameters including APD 90, APD 50 and APA were suppressed, as 
seen with cholinergic non-excitability. These dramatic effects were attributed to 
physostigmine, because a low concentration of ACh (1 µM) only reduced APD 90 and 
APD 50 and its relative effects on these parameters were smaller (approximately 30% 
reduction in APD 90 and APD 50). 
 
5.4. Effects of mancozeb and phorate (treatments 3 and 4)  
 
The last step in this series of experiments consisted of testing the effects of acute 
exposure to two commonly used AChEIs in PEI, mancozeb and phorate at high 
concentrations (10mg/L or 18.5 µM for mancozeb; 10mg/L or 38.4 µM for phorate). No 
previous studies were available in adult zebrafish, but concentrations causing 50% 
mortality (LC50) in zebrafish embryos or other species of fish were reported to be lower 
than the concentrations used in the present study. For mancozeb, reported 20h LC50 in 
zebrafish embryos was 0.4 mg/L, reported 48h LC50 in carp (Cyprinus carpio) was 4-24 
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mg/L, and reported 48h LC50 in rainbow trout (Oncorhynchus mykiss) was1.9 mg/L 
(NIH 2017). Reported 96h LC50 for phorate included 13 µg/L in rainbow trout 
(Oncorhynchus mykiss), 5 µg/L in largemouth bass (Micropterus salmoides) or 280 µg/L 
in channel catfish (Ictalarus punctatus) (NIH 2017). Despite the high concentrations 
used, the present experiments failed to demonstrate a significant cardiotoxic effect of 
mancozeb or phorate in zebrafish compared with the effect of ACh at a low 
concentration (1 µM) alone. However, one could argue that phorate caused a significant 
reduction in APA compared with baseline (- 11%), which was not observed with ACh (1 
µM) alone (- 8%). This slightly greater effect of phorate over ACh is likely not relevant 
biologically and the effect of phorate is by far not as robust as the effect seen with 
physostigmine. Moreover the statistically significant reduction in APA observed with 
phorate did not withstand Bonferroni’s correction. I suspect that although mancozeb and 
phorate have AChE inhibitory properties, they may not be as potent as physostigmine, at 
least on the atrial myocardium of zebrafish. 
 
5.5. Limitations of the study 
  
The present series of experiments had several limitations, mainly due to technical 
difficulties and its in vitro nature. It was highly challenging to maintain stable atrial 
impalements during an extended period of time to allow all necessary recordings. 
Zebrafish cardiomyocytes are small and narrow, and motion due to superfusion or 
cardiac contractions causes the microelectrode to move out of the cells easily. Attempts 
to reduce motion were made by using the excitation-contraction uncoupler blebbistatin 
(10 µM) in order to inhibit cardiac contraction without altering action potentials (Jou et 
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al. 2010). However, blebbistatin needed to be dissolved in dimethylsulfoxide (DMSO), 
which caused changes in atrial action potential morphology. The solution I chose for the 
present work consisted of using a formulation of Tyrode’s solution with a minimal 
calcium concentration in an attempt to decrease contractility and avoid excessive 
motion. 
 
Our experiments were performed at room temperature (approximately 20 °C) and 
Tyrode’s solution was not continuously gassed. The room temperature, pH and oxygen 
content of the Tyrode’s solution may have varied slightly from one experiment to 
another, which may have affected action potential parameters as previously 
demonstrated in fish (Vornanen 2016). However, to limit this problem, Tyrode’s 
solution was always made fresh and action potential parameters obtained after exposure 
to selected drugs were compared to their own baseline values recorded within an hour 
prior.  
 
The use of TMS for euthanasia may also have influenced action potential 
morphology (Ryan et al. 1993). This problem was limited by washing explanted hearts 
with Tyrode solution for at least 15 min before starting experiments and by comparing 
action potential parameters to their own baseline values (Roberts and Syme 2016). 
 
All experiments were performed in vitro on explanted hearts, removing extrinsic 
sources of cardiac control (nervous or hormonal). The effects of the pesticides that were 
used in this work may be modulated by these extrinsic sources of cardiac control and are 
likely influenced by the bioconcentration and bioaccumulation properties of each 
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toxicant. The bioconcentration factors (BCFs) of the pesticides we used have not been 
determined experimentally, but modeled BCFs suggest that physostigmine (average 
BCF: 35.2) and phorate (average BCF: 183) do not bioaccumulate substantially, whereas 
mancozeb appears to be very bioaccumulative (average BCF: 49000) (EPA 2017). In 
vivo studies may involve performing electrocardiograms on live and immobilized fish 
exposed to various pesticides, which raises ethical questions. One option may be to 
perform electrophysiological studies in euthanized zebrafish while keeping their hearts 
in situ to maintain extrinsic cardiac innervation; however, this approach is a technically 
difficult one considering the challenges encountered with explanted hearts.  
 
Finally, although zebrafish have many advantages as research models, fish kills 
in PEI involve other species of fish, which may have different sensitivities to 
environmental toxicants including AChEIs. A logical approach would be to use 
zebrafish as research models to identify possible electrophysiological mechanisms to 
explain fish kills, and then to test whether or not these findings are reproducible in 
species of fish commonly found in PEI’s rivers.  
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6. Conclusion and future directions 
 
 Fish kills are a common phenomenon in PEI and agricultural pesticides are 
suspected to be responsible for many events. However, a causal relationship is often 
impossible to demonstrate retrospectively. The present series of experiments aimed to 
investigate the possible cardiac effects of commonly used pesticides, focusing on the 
effects of AChEIs including mancozeb and phorate. While I was able to demonstrate the 
cholinergic non-excitability phenomenon, including suppression of atrial action potential 
duration and amplitude, for the first time in isolated adult zebrafish hearts exposed to the 
known AChEI physostigmine, similar toxic effects could not be observed after exposure 
to high concentrations of mancozeb and phorate. 
 
Future investigations may include testing the effects of mancozeb and phorate on 
atrioventricular conduction by performing simultaneous recordings of atrial and 
ventricular actions potentials. Indeed, the atrioventricular junction may be more 
sensitive to the AChE inhibiting effects of these two pesticides. Because no substantial 
acute effects were found with these pesticides in the present study, their chronic effects 
on electrophysiological parameters may be evaluated as well. Other types of AChEIs or 
other classes of pesticides also may be tested. 
 
Further experiments could also involve characterizing selected Na+, Ca2+ and K+ 
currents in isolated zebrafish atrial and ventricular myocytes using patch clamp 
techniques, before and after exposure to AChEIs or other pesticides. Isolation of 
cardiomyocytes could be performed using enzymatic dissociation (Brette et al. 2008; 
	   76	  
Sander 2013). These experiments could explore the precise ionic basis for the changes in 
action potential morphology previously identified, such as cholinergic non-excitability. 
They also could provide further evidence for the mechanisms responsible for the 
development of cardiac arrhythmogenesis in this context. 
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8. Annexes: raw data tables 
 
APA Treatment 1a
Exp 1 108,24 110,82 110,82 109,53 109,53 109,21 109,21 109,21 109,53 109,53 93,421 93,421 94,71 94,71 93,099 93,421 94,065 94,388 94,065 94,388
Exp 2 98,575 98,575 98,575 97,931 98,575 98,253 97,931 98,253 98,575 99,22 94,387 94,71 94,71 94,065 94,387 94,71 94,71 94,387 94,71 95,032
Exp 3 107,27 107,6 107,6 107,6 107,6 107,6 107,6 107,27 107,27 107,27 94,71 94,71 95,032 95,032 95,354 95,354 94,71 94,388 94,065 95,676
Exp 4 101,8 101,8 101,47 101,8 101,8 101,8 102,12 102,12 101,8 101,47 90,844 90,844 90,522 90,844 90,844 91,166 91,166 91,166 90,522 90,844
Exp 5 102,76 103,41 103,41 103,73 103,73 105,02 105,66 105,02 104,05 103,73 105,34 105,66 105,34 105,02 105,34 105,34 105,02 105,34 105,02 105,34
Baseline ACh 1 µM
APD 90 Treatment 1a
Exp 1 140,5 141,0 141,1 140,7 140,9 141,9 141,8 141,0 141,4 141,1 133,6 131,5 134,5 135,7 131,6 134,7 134,7 135,1 135,4 136,0
Exp 2 148,4 146,6 147,6 146,3 149,9 149,0 148,8 147,6 148,3 146,4 101,9 102,1 102,9 102,1 103,5 103,4 103,3 102,0 103,2 102,6
Exp 3 158,0 158,2 159,8 157,0 158,2 158,0 157,8 157,3 157,6 157,1 109,4 108,5 110,9 109,0 110,2 108,7 110,4 110,1 106,2 110,1
Exp 4 136,7 138,3 138,3 137,5 137,6 138,0 138,1 137,2 137,6 136,6 87,9 89,4 87,4 87,5 88,4 88,7 89,4 88,1 86,6 88,0
Exp 5 128,1 127,6 127,5 128,3 128,1 128,6 128,7 128,4 127,6 128,3 96,8 97,3 96,8 96,8 96,4 96,0 96,6 97,0 96,1 96,6
Baseline ACh 1 µM
APD 50 Treatment 1a
Exp 1 119,9 119,1 119,9 119,5 119,1 119,9 119,9 119,9 119,8 119,7 112,1 109,7 112,1 112,4 110,2 112,5 113,0 112,7 113,2 113,7
Exp 2 112,4 111,6 112,1 111,5 111,1 112,1 111,1 112,3 112,0 111,5 69,5 69,2 69,5 69,4 69,9 70,0 69,6 69,9 69,9 69,7
Exp 3 132,3 131,8 133,6 131,6 131,8 131,7 131,4 131,4 131,6 131,2 78,2 78,2 78,2 77,0 78,3 76,9 78,5 77,9 75,9 77,8
Exp 4 114,5 115,1 114,8 114,8 114,8 114,6 114,6 114,6 114,6 114,6 60,9 61,7 61,2 61,2 62,1 61,5 61,6 61,7 61,0 59,9
Exp 5 109,4 109,5 109,5 109,7 109,6 109,8 109,3 109,9 109,5 109,8 71,4 71,3 71,2 71,1 71,0 71,1 71,2 71,2 71,0 71,5
Baseline ACh 1 µM
APA Treatment 1b
Exp 1 90,8 84,7 84,1 88,6 89,2 84,1 92,5 92,5 92,1 92,1 57,3 46,7 54,4 55,7 59,0 56,7 57,0 58,0 58,0 61,5 73,1 68,3 74,1 74,1 73,4 73,4 68,9 74,4 74,4 71,8
Exp 2 102,8 103,1 102,4 103,1 102,4 103,4 103,4 102,8 103,4 103,4 81,2 82,1 82,1 81,5 81,5 81,8 82,1 81,8 81,8 82,1 87,6 87,6 87,9 87,9 88,3 88,3 87,6 88,6 88,6 87,9
Exp 3 104,4 104,4 103,7 97,9 108,9 108,9 103,1 104,1 103,7 102,4 87,3 92,1 92,8 93,7 93,4 97,9 98,6 87,9 95,0 95,0 97,3 97,9 92,1 98,6 98,6 99,5 97,3 97,6 98,3 100,2
Exp 4 81,5 80,9 81,2 79,2 84,1 84,1 82,1 83,1 80,2 80,5 54,1 57,3 57,3 53,2 52,5 55,1 57,7 56,1 57,3 54,1 94,1 96,0 96,6 94,4 94,4 93,4 95,0 96,3 96,3 95,0
Exp 5 101,2 101,2 101,8 101,5 100,5 101,2 102,1 98,3 100,5 100,5 96,0 97,9 98,6 96,3 97,6 97,0 95,0 96,3 96,3 97,0 101,8 102,1 102,1 101,8 101,5 103,1 102,8 102,4 102,4 102,1
Exp 6 83,8 82,5 83,4 82,1 82,5 83,1 82,5 81,5 82,8 81,2 46,1 46,4 48,3 48,3 45,7 45,7 45,1 47,0 46,4 46,4 71,5 71,5 70,9 71,5 75,4 74,7 70,2 70,2 68,9 98,7
Baseline ACh 10 µM Washing
APD 90 Treatment 1b
Exp 1 95,3 92,5 92,1 95,6 93,9 92,1 93,3 93,0 96,8 96,7 31,4 24,2 28,8 28,1 32,3 30,9 32,2 30,3 32,0 35,0 45,6 39,6 48,0 41,7 46,8 43,5 44,0 48,2 46,5 45,8
Exp 2 115,4 115,4 114,3 115,3 115,9 115,2 119,2 114,9 116,0 116,4 37,1 36,1 35,3 35,8 34,4 35,0 36,0 35,9 36,5 37,2 39,3 39,2 39,6 39,3 39,6 39,4 39,4 41,3 42,2 41,4
Exp 3 74,4 73,5 72,2 66,4 70,1 69,2 69,2 68,8 69,2 66,5 38,3 42,7 42,7 43,8 43,7 50,3 50,7 38,9 45,2 44,2 47,1 45,9 38,5 47,8 46,2 47,5 45,0 46,1 45,5 49,0
Exp 4 127,2 124,6 123,1 121,9 121,2 128,9 120,4 119,8 121,1 124,6 81,0 98,3 87,0 81,6 73,7 78,5 81,9 86,3 78,9 72,2 129,6 128,7 138,2 132,2 132,0 132,1 134,6 134,9 131,4 132,2
Exp 5 107,9 109,2 108,4 109,6 109,9 109,6 108,7 105,6 115,6 107,1 28,3 28,3 29,5 29,9 31,4 29,9 29,5 29,2 28,7 29,1 32,5 36,4 31,9 31,6 32,1 32,0 32,0 33,9 32,6 30,9
Exp 6 176,5 169,4 172,6 172,0 173,2 183,2 181,2 175,1 183,9 173,0 136,9 134,7 129,9 141,3 132,9 130,0 134,8 135,8 123,4 136,4 157,3 156,0 156,2 159,8 149,0 153,5 161,5 159,6 159,5 163,3
Baseline ACh 10 µM Washing
APD 50 Treatment 1b
Exp 1 77,1 76,0 75,2 78,1 76,5 76,4 74,2 76,0 78,0 78,1 18,4 15,7 17,8 18,1 18,0 17,7 18,5 17,8 18,6 18,8 26,4 24,3 27,2 23,4 26,9 25,0 26,2 27,1 26,8 27,1
Exp 2 98,1 97,6 97,2 97,7 98,2 97,4 97,5 97,9 98,2 98,3 13,0 12,5 12,4 12,7 12,8 12,3 12,5 12,7 12,6 12,6 12,7 13,0 12,8 12,9 13,3 12,9 13,5 12,9 13,5 13,5
Exp 3 51,6 51,2 51,3 50,3 50,5 49,1 50,6 50,3 50,2 49,3 18,9 20,1 20,8 20,7 21,2 21,6 21,6 19,2 20,4 20,4 18,8 18,3 17,4 18,9 18,7 18,7 18,3 18,4 18,7 18,5
Exp 4 100,2 101,8 102,5 101,4 100,8 103,2 100,0 99,5 102,0 102,1 42,4 45,5 41,9 43,4 39,5 43,2 41,9 42,5 38,7 43,6 108,1 106,5 110,2 109,5 109,5 108,4 110,0 111,7 108,6 110,4
Exp 5 81,8 80,8 81,6 81,3 83,9 82,1 81,6 80,8 81,6 80,9 13,6 13,4 13,1 13,4 13,6 13,7 13,2 13,5 13,2 13,4 15,2 15,5 15,2 15,0 15,6 15,2 15,1 15,3 15,2 15,2
Exp 6 109,6 109,6 108,3 108,2 110,1 111,4 108,3 109,9 110,8 109,3 72,1 71,5 67,3 71,4 72,8 69,8 72,9 71,6 71,2 72,4 93,5 94,4 95,7 97,3 95,7 91,5 98,4 94,3 95,7 98,7
Baseline ACh 10 µM Washing
APD 90 Treatment 1c
Exp 1 120,7 124,3 123,1 119,1 158,9 118,6 120,3 159,5 120,9 157,0 66,4 66,9 67,3 76,7 61,7 68,8 65,8 64,9 53,3 53,7 195,3 194,0 185,8 191,0 193,7 194,1 192,0 195,6 190,6 183,6
Exp 2 120,2 126,8 119,4 122,6 118,3 120,0 123,5 120,6 126,1 119,8 120,6 120,6 121,2 119,9 119,6 121,5 122,3 122,7 122,5 122,0 140,6 179,6 120,6 147,4 142,7 129,5 142,6 141,9 125,3 149,5
Exp 3 137,5 139,2 140,3 138,0 139,1 137,1 136,0 138,0 137,3 137,8 85,0 86,8 85,3 84,4 89,9 85,1 84,8 85,2 86,1 83,8 158,5 159,5 158,5 158,9 159,0 157,8 158,8 158,6 158,7 151,6
Exp 4 83,3 83,6 84,2 83,8 83,0 84,0 83,5 82,5 82,2 82,6 30,9 33,4 30,8 31,6 30,2 31,6 32,3 32,8 32,2 32,2 127,7 130,7 130,6 129,8 130,2 129,3 128,8 128,6 129,6 130,4
Baseline ACh 10 µM Atropine 1 µM + ACh 10 µM
APA Treatment 2
Exp 1 85,4 84,4 85 85 87 87 85,7 83,4 87,6 87,9
Exp 2 101,8 102,8 102,8 103,1 102,8 102,4 102,8 103,7 104,4 104,4
Exp 3 102,8 102,8 99,5 99,2 99,5 102,1 102,4 100,2 100,8 101,8
Exp 4 78,9 78,9 79,2 78,9 78,6 79,9 79,2 78,9 79,2 78,3
Exp 5 75,7 74,7 74,7 76 76,7 76,3 78,6 78,6 76,3 77
Baseline
APD 90 Treatment 2
Exp 1 134,5 131 132 132 132,4 133,2 133,9 135,3 134,3 132,2
Exp 2 152,7 153 153,6 153,7 153,5 152,5 153,3 151,7 153,8 153,5
Exp 3 103,9 101,2 100,8 100,8 100,8 103,2 100,2 102 102,2 102,8
Exp 4 126,3 127,9 126,7 128,1 125,8 126,5 126,2 124,7 125,2 124,5
Exp 5 90,1 90,4 90,3 90,8 91 91,4 95,8 93 90,3 92
Baseline
APD 50 treatment 2
Exp 1 98,0 97,9 98,8 98,2 100,7 99,5 98,9 99,8 102,2 98,2
Exp 2 126,5 126,5 126,4 126,2 126 126,1 125,7 126,1 126,5 126,1
Exp 3 82,9 80,1 79,5 79,6 80,5 83 79,9 80,2 81 82,3
Exp 4 90,9 91,2 89,7 91,4 90,9 91,7 91,2 90,1 90 87,9
Exp 5 65,5 65,7 66,2 67,4 66,6 67,6 67,2 68,2 66,7 67,4
Baseline
APA Treatment 3
Exp 1 96,3 96,6 96,6 97,3 97,3 98,3 98,6 98,3 98,6 98,6 92,8 93,4 93,7 93,4 93,7 93,7 93,4 93,4 93,7 93,7
Exp 2 88,3 88,3 88,3 88,3 88,3 88,3 87,6 87,9 87,6 87,3 76,7 76,7 77,0 77,0 76,0 76,3 76,7 76,7 76,0 76,0
Exp 3 93,1 93,1 92,8 93,7 92,8 93,7 94,1 94,1 94,1 92,8 95,0 96,0 97,0 97,0 96,3 96,3 96,3 96,6 96,6 97,0
Exp 4 89,9 90,2 91,8 91,8 90,5 90,8 91,5 90,8 89,9 90,5 71,5 72,2 73,1 71,8 71,8 72,2 69,3 70,9 69,6 72,2
Exp 5 100,2 100,2 98,9 98,3 98,3 97,6 97,6 97,3 99,5 100,2 75,7 78,9 78,9 76,3 76,3 78,6 78,6 75,1 78,3 78,3
Exp 6 97,6 98,6 98,9 99,2 98,9 98,3 98,3 98,6 98,9 99,2 91,8 91,8 91,2 91,2 92,1 92,5 92,1 91,5 91,5 91,5
Baseline Phorate 38.4 µM + ACh 1 µM
APD 90 Treatment 3
Exp 1 119,5 119,3 118,2 119,1 119,0 119,5 118,6 120,1 119,4 119,3 77,8 78,5 78,6 78,4 78,4 78,8 78,7 78,7 79,5 79,0
Exp 2 121,0 120,9 122,0 123,5 123,9 124,7 123,3 122,8 121,1 122,4 83,0 82,4 83,1 83,7 82,3 83,0 83,9 84,1 82,8 83,1
Exp 3 116,0 115,0 114,2 115,0 114,7 114,6 115,0 113,6 115,4 114,4 81,4 82,0 81,3 81,9 82,6 81,5 82,2 82,2 82,4 81,9
Exp 4 131,4 130,6 128,0 127,5 126,8 128,6 129,8 130,3 127,0 129,2 56,1 55,0 54,0 57,1 55,9 57,6 55,1 59,7 63,3 57,0
Exp 5 123,3 122,2 119,9 119,4 118,6 119,1 118,7 117,7 123,7 122,2 57,5 57,2 57,0 56,3 56,3 56,5 60,8 59,9 57,2 58,5
Exp 6 127,9 129,6 128,9 129,4 129,6 129,2 128,4 129,4 129,1 130,7 95,8 96,2 96,4 96,0 97,2 96,8 95,9 97,3 96,1 97,9
Baseline Phorate 38.4 µM + ACh 1 µM
APD 50 Treatment 3
Exp 1 102,1 102,1 100,5 102,1 101,7 102,0 100,6 102,7 101,7 102,0 45,7 45,7 45,6 45,8 45,2 45,8 45,6 45,7 45,9 45,4
Exp 2 95,9 96,0 96,3 96,4 96,5 96,3 96,4 96,2 95,8 96,2 49,1 49,5 49,8 49,8 49,3 49,3 50,1 49,9 50,1 49,5
Exp 3 93,0 93,2 93,3 93,3 93,4 93,2 93,2 93,0 93,5 93,1 53,9 53,6 54,1 53,4 54,0 54,2 53,7 54,4 53,9 54,3
Exp 4 98,5 99,0 98,7 98,0 97,5 99,2 97,0 98,5 97,0 98,7 28,0 27,9 27,8 28,8 28,6 27,8 28,6 28,8 29,2 28,9
Exp 5 104,7 103,3 100,5 100,3 99,5 99,8 99,0 98,7 105,0 103,5 24,5 22,7 22,9 24,1 23,1 22,9 24,6 23,6 23,4 23,8
Exp 6 106,0 106,8 106,9 107,0 106,2 106,9 106,6 107,5 106,6 107,1 66,5 67,3 67,2 67,2 67,4 68,0 67,4 67,0 68,2 68,0
Baseline Phorate 38.4 µM + ACh 1 µM
APA Treatment 4
Exp 1 87,6 88,6 88,6 87,9 87,9 87,9 87,9 89,2 89,2 88,6 93,1 93,1 92,8 92,5 92,1 92,1 92,1 92,1 92,5 92,5
Exp 2 105,0 106,0 106,6 106,6 107,0 107,0 106,0 105,7 106,6 106,6 103,7 103,4 104,1 104,7 105,0 105,3 105,3 104,7 105,3 105,3
Exp 3 91,8 92,1 92,1 91,5 91,5 91,2 91,2 91,2 91,2 91,8 102,8 104,1 104,1 104,1 104,4 104,4 104,1 104,4 105,0 104,4
Exp 4 107,6 107,6 107,6 107,3 107,6 107,6 107,0 107,3 107,0 107,0 102,4 103,1 103,1 103,1 102,1 102,1 102,1 102,1 102,1 102,1
Exp 5 87,3 89,9 90,5 89,9 90,8 90,5 90,5 91,2 90,8 90,8 109,5 110,2 109,9 109,5 110,2 110,2 109,9 109,9 109,9 109,9
Exp 6 93,4 94,1 94,1 93,7 94,4 94,1 93,7 93,7 93,7 94,1 86,3 86,3 86,7 86,7 86,7 86,3 86,7 86,7 86,3 85,7
Baseline Mancozeb 18.5 µM + ACh 1 µM
APD 90 Treatment 4
Exp 1 90,3 92,9 91,0 91,7 91,3 91,6 91,5 94,6 91,2 90,8 73,2 72,8 73,5 72,7 73,0 72,1 72,4 72,9 72,7 73,3
Exp 2 138,9 143,3 141,4 138,7 145,8 142,2 140,8 142,5 137,4 141,0 136,8 134,1 137,6 136,5 137,4 139,0 139,6 139,3 140,5 138,0
Exp 3 121,6 123,0 123,1 123,0 122,7 121,4 120,6 121,0 120,9 120,6 95,2 93,7 93,6 94,6 94,1 93,6 94,6 93,8 94,7 94,3
Exp 4 131,5 131,7 131,3 130,8 131,8 131,1 130,4 131,4 130,9 130,9 98,5 98,1 98,3 98,4 97,5 95,7 95,9 96,4 97,7 97,7
Exp 5 143,5 146,2 143,7 144,3 143,5 143,6 145,0 144,6 145,5 145,4 134,0 133,8 133,6 133,4 133,7 133,5 133,2 133,3 133,3 133,4
Exp 6 147,4 141,1 146,0 145,5 145,1 143,6 145,8 144,7 143,8 142,6 63,2 63,2 63,6 63,5 63,4 63,0 63,3 63,0 62,6 61,3
Baseline Mancozeb 18.5 µM + ACh 1 µM
APD 50 Treatment 4
Exp 1 71,8 74,6 72,4 72,7 72,3 72,2 72,4 75,5 73,0 72,5 48,2 47,8 48,5 47,9 48,3 47,9 48,1 48,3 47,9 48,1
Exp 2 118,5 121,2 119,9 114,5 122,1 119,1 119,8 120,9 115,2 117,5 115,6 113,2 116,4 115,6 116,2 117,5 118,2 117,8 119,1 115,9
Exp 3 101,8 102,7 102,7 102,8 103,3 101,9 101,3 101,9 101,6 101,5 70,7 70,0 70,0 70,3 70,4 70,4 70,1 70,3 70,6 70,2
Exp 4 108,3 108,3 108,2 108,2 108,7 108,6 108,0 108,1 108,1 108,0 72,7 72,2 72,0 71,9 71,4 70,6 70,5 70,9 71,4 71,3
Exp 5 120,4 122,5 120,6 120,9 120,9 120,8 122,4 120,7 122,2 122,3 114,4 114,3 114,0 113,5 114,2 114,1 113,8 113,7 113,8 114,0
Exp 6 108,8 109,4 108,2 110,4 106,9 107,6 108,5 107,9 107,6 107,6 34,5 34,6 34,4 34,0 33,9 34,2 33,7 34,0 33,4 33,1
Baseline Mancozeb 18.5 µM + ACh 1 µM
